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CHAPTER 1 
Introduction and objective of the thesis 
 
Abstract 
Poly(lactide-co-glycolide) (PLGA) microparticles as an injectable dosage form for a 
controlled release of peptides, proteins or poorly water soluble drugs are of 
considerable interest for research as well as for commercial scope since the 1970´s. 
Also there is a variety of techniques to encapsulate a drug substance in a PLGA 
matrix, only few of them are successfully used for the industrial scale production of a 
microparticulate dosage form. One of the oldest and most common used techniques 
is the emulsion solvent removal technique. The properties of PLGA microparticles 
prepared by this technique considerably depend on the applied process parameters. 
Especially the rate of solidification of the liquid emulsion droplets to solid 
microparticles has an impact on their morphology and physico-chemical properties. 
The relationship between process parameters, solidification rate and the properties 
of the resulting microspheres and especially the control of the latter are still not fully 
understood. A better understanding of this interrelation is necessary for the control 
and up-scale of a microparticle manufacturing process.  
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1 Introduction 
The encapsulation of drugs into a polymeric matrix can greatly enhance the drug 
safety and efficiency and allows modifying the release kinetics. Thus the interest 
and research in these controlled release dosage forms increased steadily over the 
past decades. Polymeric matrix systems are available e.g. for per oral (e.g. 
embedding the drug substance in an insoluble PVC-matrix (Duriles® technology)), 
transdermal (matrix patches) as well as for parenteral application (e.g. as monolitihic 
implants or microspheres). The release period from these dosage forms can range 
from several hours to a few months. 
As a large proportion of new drugs are peptides or proteins with short half-live or low 
molecular compounds with poor solubility, biodegradable polymer microparticles for 
parenteral application provide a suitable delivery strategy. With Lupron®Depot, a 
sustained release dosage form of Leuprorelide acetate for the treatment of prostate 
cancer or endometriosis, sales of 1.97 billion US$ were generated in 2009. In the 
same year with Risperdal consta®, a drug product for the treatment of 
schizophrenia, sales of 1.42 billion US$ were achieved [1]. These data underscore 
the commercial relevance of these dosage forms which is still increasing. 
Biodegradable microparticles provide a variety of advantages like the maintenance 
of drug levels in a therapeutically desired range, a reduction of side effects and a 
decreased frequency of drug administration leading to an enhanced compliance rate 
[2, 3]. Especially concerning psychological diseases long acting dosage forms are 
able to increase the success of the treatment, as patients may be reluctant to take 
these medications on their own. 
Biodegradable polyesters, like Poly(lactide-co-glycolide) (PLGA) are among the 
most often used biodegradable polymers for parenteral matrix formulations, as they 
are biocompatible and degrade into non-toxic oligomers and finally monomers. With 
PLGA different release periods can be obtained by utilizing different ratios of lactic 
to glycolic acid in the polymer. Higher lactic acid content leads to a prolonged 
release because of the enhanced hydrophobicity, whereas polymers with a higher 
content of glycolic acid degrade more rapidly since water can faster penetrate into 
the more hydrophilic polymer matrix. 
In addition, there is a multitude of different methods for the manufacturing of PLGA 
microparticles. The appropriate choice is thereby primarily determined by the 
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properties of the polymer, the drug to be encapsulated and the targeted release 
profile. The solvent extraction evaporation method is a preferred and versatile 
technique. In this process a multitude of process parameters has an impact on the 
microparticle properties and the resulting release rate. A thorough understanding of 
the individual process steps is essential for the development of a product with 
specific characteristics. This also includes monitoring and control of the process by 
Process Analytical Technologies (PAT).  
According to IUPAC polymer microparticles are particles of any shape or form with a 
size of 0.1 to 100 µm. In pharmaceutical literature the term “microparticles” is also 
used for particles up to 1000 µm. Two general morphologies of microparticles can 
be distinguished: i) microspheres, in which the drug substance is homogeneously 
dissolved or dispersed within a polymeric matrix and ii) microcapsules, in which a 
drug containing core is completely surrounded by a polymer shell; the core can be 
solid, liquid or gaseous. Both morphologies differ in their release behavior. The main 
advantage of microspheres is that severe drug burst due to a rupture of the polymer 
shell cannot occur. Since 1970 biodegradable polymers are designed and used for 
controlled release applications. One of the first and most widely used polymer 
groups are the polymers and copolymers of lactic and glycolic acid: PLA, PLG and 
PLGA (Fig. 1). 
 
Polylactic acid (PLA)     Polyglycolid acid (PGA)   Poly(lactid-co-glycolide(PLGA) 
Figure 1:  Molecular structure of polylactic acid, polyglycolic acid and polylactic/glycolic copolymer 
Due to their biodegradation these polyesters do not require surgical removal and the 
resulting monomers, lactic and glycolic acid are two physiological occurring 
substances and pose no major toxicological problems. Another benefit of PLGA is 
that the drug release duration can be tailored from several days to more than one 
year, depending on the composition of the polymer, the geometry of the device, the 
method of preparation and the drug substance to be encapsulated. The drug 
release from PLGA microspheres is a complex process depending on two 
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mechanisms, the diffusion controlled release of the drug substance from the 
microspheres and the polymer erosion [4]. The initial phase of drug release, where 
the drug release according to a diffusion mechanism of the drug substance, is 
strongly dependent on the properties of the drug substance itself, e.g. its water 
solubility and the solubility in the polymer phase, the morphology of the polymer 
matrix, e.g. the porosity, the “loading of the microspheres (polymer/drug ratio) and 
the particle size. 
In contrast to large-size PLGA devices for microspheres with less than 300 microns 
diameter the polymer erosion is considered to be a bulk process [5, 6]. The 
biodegradation is considered to be mainly a non-enzymatic hydrolytic cleavage of 
the ester bonds [7-9]. The hydrolytic degradation of the PLGA matrix is affected by a 
multitude of factors (Tab. 1).  
Table 1:  Factors affecting the hydrolytic behavior of biodegradable polyesters 
 Water Permeability and hydrophilicity 
 Chemical composition (glycolid-lactid-ratio) 
 Crystalline or amorphous state of the polymer 
 Additives (acidic, basic, monomers, solvents, drug) 
 Mechanism of hydrolysis (autocatalytic, non-catalytic, enzymatic) 
 Device dimension 
 Porosity 
 Glass transition temperature 
 Molecular weight of the polymer 
 Physico-chemical factors (ion exchange, ionic strength, pH) 
Source: modified from Anderson, JM [3] 
The main factors are (a) the hydrolytic susceptibility of the ester bonds, (b) the 
diffusion coefficient of water within the matrix, (c) the diffusion rate of the chain 
fragments within the matrix and (d) the solubility of the oligomers in the surrounding 
medium. The hydrolytic degradation behaviour can be modulated by different 
factors, e.g. the ratio of lactic acid to glycolic acid in the copolymer. The higher the 
content of lactic acid moiety in the copolymer is, the slower becomes the 
degradation rate [10]. With a higher content of glycolic acid in the polymer, the chain 
cleavage can occur more easily because of the better accessibility of the glycolide-
glycolide- and glycolide-lactide-bonds [11]. Furthermore, amorphous polymers or 
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amorphous domains in the polymer degrade faster than crystalline regions. The 
amorphous parts are more accessible to water than the crystalline ones and thus 
the degradation proceeds faster. 
Besides these chemical factors also the morphology of the polymer matrix, 
especially the porosity can have a great influence on the degradation behaviour of 
PLGA microspheres. It influences not only the transport of the drug substance out of 
the microspheres, but also the inward transport of water and the outward transport 
of oligomers and monomers generated during the degradation. In addition, if the 
polymer matrix is very dense and degradation products accumulate inside the 
microspheres, the carboxylic chain ends and thus the decrease in pH can facilitate 
an autocatalytic degradation of the polymer [4, 12]. 
2 Encapsulation Processes 
Numerous methods for preparation of biodegradable microspheres for parenteral 
application are known and the manufacturing technique has a great influence on the 
resulting microparticle properties, like particle size, porosity or surface morphology. 
For a parenteral application the diameter of the microspheres should be less than 
250 µm to allow injection with needles of acceptable diameter. Furthermore the 
microparticles should show a good suspensibility prior to application in order to 
obtain stable and homogeneous suspensions for proper dosing. Apart from these 
considerations the process should be well controlled and easy to scale up. For the 
preparation of PLGA microparticles the most widely used techniques briefly 
described below. 
2.1 Coacervation 
The application of coacervation methods for the preparation of microcapsules for 
pharmaceutical purposes started in the 1960s, e.g. to encapsulate acetylsalicylic 
acid and procaine penicillin G [14, 15]. The first PLGA drug microspheres prepared 
by coacervation contained nafarelin, a luteinizing hormone-releasing hormone [16, 
17]. The term coacervation in this context refers to the embedding of a drug 
substance in a polymeric matrix by phase separation. It is characterized by the 
appearance of a polymer-rich phase and a second phase, mainly consisting of the 
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solvent. In this process the drug substance is suspended or dissolved in a solution 
of the polymer. In case of PLGA as the polymeric component methylene chloride is 
a common solvent. The polymer separation as a viscous liquid phase can be 
induced by several methods. In simple coacervation processes the formation of the 
polymer-rich phase is generated by the addition of the coacervating agent, typically 
silicon oil. Above a critical volume fraction of the silicon oil, which depends on the 
given polymer concentration, the polymer molecular weight and the temperature, 
phase separation occurs. The forming coacervate droplets are subsequently 
hardened by adding a hardening agent like hexane or octamethylcyclotetrasiloxane. 
A drawback of this process is the problem of residual coacervating or hardening 
agent in the microspheres, which reduces biocompatibility. In other methods the 
precipitation of PLGA from a water-miscible organic phase is caused by emulsifying 
in a salt solution (“salting out”).  
Today there are several commercially available PLGA microsphere products 
prepared by phase separation on the market. Decapeptyl® Depot (Ferring 
Pharmaceuticals, Suffern, New York, USA) is a PLGA microparticle formulation 
encapsulating Triptorelin acetate for prostate cancer endometriosis treatment. 
Sandostatin® LAR® (Novartis Pharma, Basel, Switzerland) contains octreotide 
acetate, a synthetic analogue of somatostatin. Although coacervation is mainly 
applied for water soluble drugs, it can be used for hydrophobic drugs as well [18]. 
2.2 Spray drying, spray congealing 
In spray drying typically the polymer and the drug substance are dissolved, the 
solution is spray-atomized into a gas stream, the solvent evaporates and solid 
particles are formed. It can be applied to encapsulate hydrophilic as well as 
lipophilic drugs. The benefits of spray drying are the short manufacturing time and 
easy scale up [19]. Besides the process parameters like e.g. pump rate or drying 
time, also the concentration of the polymer – drug – solution and the solvent 
composition have an influence on the morphology and drug release of the resulting 
microspheres [20, 21]. It can be difficult to obtain spherical particles and often the 
microspheres are irregularly shaped [22]. Another limitation of this process is that 
only small particles in the lower micrometer range (<15 µm) are obtained. 
Furthermore the resulting microparticles are usually hollow and porous spheres, 
which increases drug release as the water uptake is thereby enhanced. The first 
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pharmaceutical application of this process for the commercial production was the 
encapsulation of bromocriptine in poly(L-lactic acid). Today this product is prepared 
with a star branched polyester poly(D,L-lactide-co-glycolide-D-glucose) and 
marketed under the trade name Parlodel LAR™ (Sandoz (Novartis) Pharma, Basel 
Switzerland) [23-25].  
2.3 Methods using supercritical fluids (SCF) 
A supercritical fluid is a substance either liquid or gas, above its critical temperature 
and critical pressure, where gases and liquids can coexist. It exhibits the flow 
properties of a gas and the dissolving power of a liquid. Most commonly CO2 is used 
as a SCF. There are many different methods to form microparticles by using SCF 
[26]. As PLGA has only a limited solubility in supercritical CO2, the supercritical fluid 
is normally used as an antisolvent. This principle is applied in the Supercritical 
Antisolvent process (SAS) or Gas Antisolvent process (GAS). The polymer and drug 
substance are dissolved in a liquid organic solvent, for example methylene chloride. 
Then the solution can be either sprayed into the supercritical CO2 or precipitation of 
the microparticles is induced by injecting supercritical CO2 into the solution phase 
[27, 28]. In a modified version of the SAS process, the Solution Enhanced 
Dispersion by Supercritical Fluids process (SEDS) the drug-polymer-solution and 
the SCF are sprayed together through specially designed two or three channelled 
nozzles. A disadvantage of this process is that large quantities of organic solvents 
and surfactants remain in the microspheres and that a wide size distribution of 
particles is obtained. A molten polymer-drug-mixture can also be saturated with SCF 
and then sprayed through a nozzle (the Particles from Gas Saturated Solutions 
process (PGSS). The mixture is solidified by the cooling effect due to the large 
expansion and pressure reduction during spraying. With this process an efficient 
incorporation of a drug substance with a homogeneous distribution throughout the 
polymer matrix can be obtained [29, 30].  
2.4 Solvent removal process 
One of the simplest and most widely used techniques to prepare PLGA 
microspheres containing a hydrophobic drug is the emulsion solvent removal 
process [31, 32]. It consists mainly of four steps: i) formation of a solution or 
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dispersion of the active ingredient and the polymer in a volatile organic solvent, ii) 
formation of a primary emulsion by emulsifying the organic phase in a continuous 
(mostly aqueous) phase, iii) feeding the primary emulsion into a surplus of 
continuous phase and removal of the organic solvent by extraction / evaporation 
and iv) hardening of the emulsion droplets and finally harvesting and drying of the 
microparticles (Fig. 2). 
 
Figure 2: Schematic diagram of a common O/W emulsion solvent evaporation process 
After the formation of an organic solution or dispersion containing the drug 
substance and the polymer this organic phase is emulsified using a stirrer, a 
sonicator or a homogenizer. This primary emulsion is then passed into a surplus of 
outer aqueous phase containing stabilizers like polyvinylalcohol, sorbitanester, 
polysorbate or other surface active substances. By discharging the primary 
emulsion into the large quantity of outer phase the organic solvent is extracted from 
the droplets, which implies a certain solubility of the organic solvent in the aqueous 
phase. The organic solvent is then released via evaporation in the gas phase. By 
extraction and evaporation of the organic solvent, the emulsion droplets are 
hardened and microspheres with a size range generally between 5 to 250 µm are 
obtained. The emulsification-solvent evaporation technique is mainly used for 
encapsulating proteins or drugs, which are insoluble or poorly soluble in water. The 
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release properties of the microparticles can be tailored via the employed solvents, 
the ratio of the dispersed to continuous phase, the viscosity of the solution, the 
temperature of the external phase and others [31, 33, 34]. On industrial scale this 
technique is used for the production of Vivitrol® (Cephalon,Inc., Frazer, USA) [35]. 
Variations of this technique include the formation of a multiple emulsion (w/o/w-
method) or the utilization of an external oil phase, like paraffin oil, in case of water 
soluble drugs. The w/o/w-double emulsion method is especially suitable for the 
encapsulation of proteins, peptides, vaccines or other water soluble 
macromolecules to obtain microparticles with sufficient encapsulation efficiency. 
With an o/w-emulsion process however, the encapsulation efficiency is very low 
because the drug easily dissolves in the outer aqueous phase. A parenteral depot 
formulation with leuprorelide acetate is manufactured by the w/o/w method and is 
marketed under the trade name Enantone™ (Takeda Pharmaceutical Company 
Limited, Osaka, Japan). For hydrophobic drugs this technique seems not beneficial. 
However, by adding an inner water phase in the w/o/w process the porosity of the 
microparticles and thus the drug release can be modified [36-38]. 
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3 The solvent removal process for manufacturing of 
PLGA microspheres on an industrial scale 
For the commercial production of PLGA microspheres coacervation, spray-drying 
and solvent extraction /evaporation are applied. Table 2 shows a selection of 
marketed microparticulate dosage forms and the applied encapsulation technique.  
Table 2: List of marketed PLGA microparticle formulations * 
Drug Product Distributor 
Encapsulation 
technique 
Ocreotide acetate 
Sandostatin LAR® 
Depot 
Novartis Coacervation 
Lanreotide acetate Somatuline® Depot Ipsen Coacervation 
Naltrexone Vivitrol® Alkermes 
o/w emulsion 
solvent extraction 
Risperidone Risperdal® consta 
Janssen / 
Alkermes Inc. 
o/w emulsion 
solvent extraction 
Leuprorelide 
acetate 
Lupron Depot® 
TAP 
Pharmaceuticals 
w/o/w emulsion 
solvent 
evaporation 
* modified from Kumar and Palmieri, 2010 [39] 
The emulsion solvent extraction evaporation method is a straightforward method for 
the preparation of microspheres and most widely used on a laboratory scale. Due to 
the fact that the product properties are influenced by a large number of process 
variables (Fig. 3), the transfer from laboratory scale to commercial production is 
often associated with difficulties. 
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Figure 3: Parameters influencing the product properties of the resulting PLGA microparticles 
For a manufacturing process of PLGA microparticles with defined composition, the 
properties of the resulting product will be strongly influenced by the chosen process 
parameters, like e.g. stirring speed, temperature of the continuous phase and 
others. These process parameters influence strongly the rate and time point of the 
transformation from liquid emulsion droplets to solid particles. This in turn has a 
great impact on the physico-chemical properties of the latter. 
During the conversion of the liquid emulsion droplets into solid particles different 
events take place: (a) diffusion of the organic solvent from the embryonic particles 
into the aqueous medium, (b) in return diffusion of the aqueous medium in opposite 
direction, (c) polymer phase separation on the particle surface, (d) drug loss into the 
quench solution and (e) evaporation of the solvent. All these coupled events 
influence each other. How fast these different processes occur has an impact on the 
rate of solidification of the microspheres, which in turn influences the resulting 
particle characteristics [40]. 
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3.1 Influences of process parameters on the solidification rate of 
the microparticles 
Hardening of the polymer matrix occurs as the organic solvent is extracted from the 
emulsion droplets. The extraction process itself can be controlled by a variety of 
process parameters (Fig. 4). It is influenced amongst others by the ratio of 
dispersed phase to continuous phase, the temperature of the extraction medium, 
the stirring speed, the solvent exchange at the emulsion droplet – extraction 
medium interface and subsequent gas exchange on the surface of the external 
solution, the pressure in the vessel and the gas flow removing the organic solvent. 
The temperature is rather simple to control for a process with a constant 
temperature during manufacturing, but sometimes temperature ramps are applied 
which need to be controlled precisely [41]. As the temperature of the continuous 
phase is adjusted by the heating jacket of the reactor, the temperature change is 
delayed if the volume is increased. While the heated area changes with the second 
power, the volume of the quench solution is linked with the third power. Another 
difficulty is the flow conditions in the reactor. The agitation depends on the stirrer 
geometry and the stirring speed, but considering the geometry of the reactor this 
might not be a simple scale-up factor. Once transferred into the aqueous phase the 
solvent is conveyed to the interface between quench solution and head space. This 
mass transfer is related to the relative velocities of particles, resp. gas molecules 
and the fluid in the system, the viscosity of the liquid, and the solubility of the solvent 
in the extraction medium. The flow pattern in the reactor crucially depends on the 
stirrer speed and stirrer position given that the stirrer geometry does not change.  A 
certain stirrer speed is required to obtain a mixing of the total volume in the reactor 
and thus to enhance the transport of the gas molecules to the liquid – gas interface. 
The driving force for the mass transfer from the extraction medium to the head 
space above is the concentration gradient on both sides. The faster the gas 
molecules are removed from the gaseous side of interface, e.g. by feeding air 
through the head space of the reactor, the faster the evaporation rate. By increasing 
the volume of the extraction phase the interface does not equally increase, meaning 
that the solvent is faster extracted from the emulsion droplets but not from the 
extraction medium and thus influencing the solidification rate of the droplets as 
described below. 
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Figure 4: Process parameters influencing the rate of solvent removal from the emulsion during 
solvent extraction / evaporation process for PLGA microparticles. 
3.2 Influence of the solidification rate on particle properties 
 Fast polymer precipitation results in a porous inner structure and smooth surface of 
the microparticles. The encapsulation efficiency is typically high, as the solid 
polymer film, which is formed rapidly on the particle surface, acts as a diffusion 
barrier for the drug [42]. In contrast, slow polymer precipitation results in a dense 
polymer structure, but skin formation is slower and the polymer matrix stays soft for 
a long time span. This allows an enhanced influx of water during solidification and 
the formation of water pockets leading to cavities in the dried microparticles [43]. 
Besides the varying drug loading of the final microspheres also their drug release 
depends on the formation process and the resulting particle morphology. The 
diffusion-controlled release is higher for porous microparticles, as the drug needs to 
pass to the particle surface either through the polymer matrix or through pores. 
Furthermore, an open porous microparticle structure can lead to a significant burst 
effect [44]. In return water can enter the particles through these pores and fill the 
inner cavities inside the particles. Degradation of the polymer matrix is accelerated 
from the inside by these water-filled cavities in the interior of the particle leading to a 
faster drug release [45].  
Due to the fact that the precipitation rate has such an influence on the resulting 
particle characteristics, it is essential to control the parameters which affect the 
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solvent removal and the precipitation during microparticle processing carefully [46-
48]. 
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4 Objective of the Thesis 
The goal of the thesis was to understand the mechanism of microparticle formation 
in an emulsion solvent extraction / evaporation process for the preparation of drug 
loaded PLGA microspheres on a 5 L batch scale. The model drug selected was 3-
{2-[4-(6-fluor-1,2-benzisoxazol-3-yl)piperidono]ethyl}-2-methyl-6,7,8,9-tetrahydro-
4H-pyrido[1,2-a]pyrimidin-4-on. It has to be considered, that the drug substance is 
hydrophobic and poorly water soluble and thus provides several challenges for the 
encapsulation and the release.  
On this basis the key process parameters influencing particle morphology and their 
impact on the resulting drug release profiles were to be identified. In the applied 
emulsion solvent extraction / evaporation process the morphology and particle size 
distribution is the result of a primary structure formation at the beginning of the 
process and secondary structural changes during processing. The understanding of 
these processes is essential for the control of the preparation process and a 
prerequisite for a successful upscale to commercial manufacturing.  
The main objectives of this thesis were: 
 Characterization of drug-polymer interactions and evaluation of possible 
solvent and solvent mixtures by the Hansen solubility parameters and their 
impact on the resulting drug and particle morphology (CHAPTER 2) 
 
 Control of the droplet of the primary emulsion in a solvent removal process 
(CHAPTER 3) 
 
 Monitoring and understanding of the structural changes during the process by 
focused beam reflectance measurement (CHAPTER 4) 
 
 Understanding the influence of process parameters like temperature, type of 
polymer and post-treatment of the particles on particle morphology 
(CHAPTER 5) 
 
 Characterization of the microparticle morphology by determination of the 
porosity and the pore size distribution (CHAPTER 6) 
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CHAPTER 2 
Application of Hansen solubility parameters for 
understanding and prediction of drug distribution 
in microspheres ‡ 
 
Abstract 
In an emulsion solvent extraction / evaporation process for the preparation of 
microspheres the employed solvents have a tremendous influence on the 
characteristics of the resulting particles. Nevertheless the solvent selection is often 
based on empirical data rather than on calculated values. The purpose of this 
investigation was to use the concept of solubility parameters for interpretation and 
improved understanding of solvent effects in the process of microparticle 
preparation. Partial solubility parameters of 3-{2-[4-(6-Fluor-1,2- benzisoxazol-3-yl) 
piperidino]ethyl}- 2-methyl-6,7,8,9- tetrahydro-4H-pyrido [1,2-a]pyrimidin-4-on, which 
was used as a model drug, were determined experimentally using an extended 
Hansen regression model. Poly(lactide-co-glycolide) microparticles were prepared 
with an emulsion solvent removal process employing methylene chloride and its 
mixtures with benzyl alcohol and n-butanol. It could be shown, that the 
encapsulation efficiency was influenced by the change of the solvent composition 
during the extraction process. Furthermore the solvent selection had an essential 
influence on the morphological state of the drug and it could be shown and 
explained, that by a decrease of the dissolving power a completely amorphous 
product was obtained. 
 
‡ 
Published in International Journal of Pharmaceutics, 2011, 416 (1), p. 202-209: Vay,K.; Scheler,S.; 
Friess,W. Application of Hansen solubility parameters for understanding and prediction of drug 
distribution in microspheres. 
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1 Introduction 
The microencapsulation of a drug substance in a polymeric matrix offers the 
possibility of a controlled drug release with many clinical benefits like the drug 
targeting to a specific location or higher compliance of the patient because of a 
reduced dosing frequency. There are several methods to prepare microspheres 
from preformed polymers and the emulsion solvent extraction / evaporation process 
is one of the most frequently used techniques. In this preparation process, the 
properties of the utilized solvents are among the primary factors determining the 
characteristics of the resulting microspheres [1-4]. Nearly every step of the particle 
formation process is affected by the solvents in a distinct way. In the first step where 
an organic solution of the polymer or, as in most cases, a solution of drug and 
polymer is formed the dissolving power of the solvent determines the upper 
concentration limit of the organic phase. If it is not intended to incorporate the drug 
as a suspension, both, drug substance and polymer should be well soluble in the 
organic solvent. In a second step an emulsion is formed from this solution and an 
aqueous phase. By feeding the emulsion into a stirred reactor containing an 
aqueous medium, the solvent is extracted into the external phase from where it can 
be evaporated in case of volatile solvents. During this process different diffusion 
processes take place like the transfer of the organic solvent out of and in return the 
non-solvent into the microspheres. This solvent exchange causes the transformation 
of the droplets into solid microspheres and is determined by the miscibility of the 
solvents and the aqueous medium. The drug, however, ideally should not be soluble 
in the aqueous medium otherwise it will be leached out of the particles resulting in 
low encapsulation efficiency [5]. 
A variety of different solvent parameters like volatility and boiling point, reactivity or 
viscosity have to be considered in order to tailor the resulting microparticle 
properties. Another critical factor is the toxicological safety, as a certain amount of 
solvent residues remains in the product and thus restricts the range of suitable 
solvents. However one of the most important criterions on which a suitable solvent 
has to be chosen is an optimum balanced affinity to the other process compounds. 
Often the solvent selection is based on empirical data rather than on calculated 
values. An initial estimate based on solubility calculations can help to optimize the 
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results and to minimize experimental expenditure. An established tool to estimate 
the solubility behaviour of a substance is the concept of solubility parameters, 
originally defined by Hildebrand [6]. He proposed the square root of the cohesive 
energy density as a numeric value to specify the solubility characteristics of a 
specific solvent: 
mVRTH /         (1) 
where ΔH is the heat of vaporization, R is the gas constant, T is the temperature 
and Vm is the molar volume. The cohesive energy density of a liquid is the energy of 
vaporization per volume unit. It reflects the degree of attractive forces holding the 
molecules together. This amount of energy is required to separate the atoms or 
molecules of the material from each other and is the effect of all interatomic / -
molecular interactions. Hansen subdivided the total Hildebrand value δt into three 
fractions: dispersive interactions (δd), polar interactions (δp) and hydrogen bonding 
(δh). These 3 parameters can be visualized as coordinates in a 3-dimensional 
diagram, which allows a good illustration of the miscibility or solubility of different 
materials. The smaller the distance between the coordinates of two substances is in 
this 3-dimensional space, the better is their mutual solubility.  
In this study the principle of Hansen solubility parameters was applied to an 
emulsion-solvent evaporation process for the preparation of PLGA microspheres. 
Moldenhauer and Nairn used Hansen solubility parameters to choose alternative 
solvent systems for the production of microcapsules with similar properties and 
showed that particle characteristics and release rates could be correlated with the 
solubility parameters of solvent mixtures [7]. Bordes et al. applied them for the 
solvent substitution in a microencapsulation process with poly(ε-caprolactone) [8]. 
The objective of our work was to optimize the particle characteristics by modifying 
the solvent mixture of the dispersed phase. Starting with methylene chloride, which 
is often used in this process, binary mixtures of methylene chloride with benzyl 
alcohol and n-butanol were tested to analyze their influence on the morphology of 
the drug substance, the encapsulation efficiency and the drug release rate. 
Furthermore the solubility of the drug in the polymer matrix could be estimated.  
Experimentally determined Hansen parameters of a huge number of solvents, drug 
substances and other chemicals are listed in the literature. However no values can 
be found so far for 3-{2-[4-(6-Fluor-1,2-benzisoxazol-3-yl)piperidino]ethyl}-2-methyl-
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6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-on. In this study we determined these 
parameters experimentally and compared them with those obtained by group 
contribution methods according to Hoftyzer / Van Krevelen and Hoy.  
2 Materials and Methods 
2.1 Materials 
3-{2-[4-(6-Fluor-1,2-benzisoxazol-3-yl)piperidino]ethyl}-2-methyl-6,7,8,9-tetrahydro-
4H-pyrido[1,2-a]pyrimidin-4-on was obtained by Jubilant Organosys (Mysore, India) 
with an assay of 100.2% and 0.19% total impurities (main impurities: N-Oxide-
Derivative and 9-OH-Derivative); Poly(D,L-lactide-co-glycolide) 75:25 (Resomer 
755 S), Mw = 64710 Da was purchased from Boehringer Ingelheim, (Ingelheim, 
Germany). All solvents used were of analytical grade and were used as obtained. 
2.2 Determination of the solubility of the API in PLGA by 
differential scanning calorimetry (DSC) 
To determine the solubility the drug substance in PLGA the enthalpy of fusion of 
pure PLGA, drug substance and three mixtures of PLGA with 30.9%, 49.3% and 
81.8% of API were measured. Approximately 2 mg were weighed in a standard 
aluminium pan, sealed and heated from -20 to 250 °C with a heating rate of 50° per 
minute in a DSC (823e/500) from Mettler Toledo (Greifensee, Switzerland). The 
melting peak of the drug substance at 170 °C was integrated. The heat of fusion 
thus obtained was plotted against the dug concentration in the mixture as described 
in literature [9] (Panyam et al, 2004). 
To examine if the decomposition occurs the pan with pure drug substance was 
heated for a second time up to 250 °C. The thermogram was unchanged compared 
to the first one indicating that the drug substance is stable in a range between -20 
and 250 °C. PLGA is described in literature to undergo no decomposition in this 
temperature range [10]. 
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2.3 Determination of the morphological state of the drug by X-Ray 
powder diffractometry 
X-ray powder diffraction (XRPD) patterns were collected with an Unisantis XMD 300 
X-ray powder diffractometer (Unisantis, Georgsmarienhütte, Germany) with a 
position sensitive detector in parallel beam optics using the following acquisition 
conditions: tube anode: Cu, 40 kV, 0.8 mA; 3-43° theta/2theta; simultaneous 
detection of regions of 10° per step with detector resolution 1024, counting time 300 
seconds per step. Samples were measured at room temperature in a standard 
sample holder on a rotating sample spinner.  
2.4 Determination of the solubility 
The solubility of on the API was determined in 17 different solvents (Table 1) by 
adding a surplus of drug substance in a glass vial to 5 ml solvent. The vials were 
sealed and shaken at room temperature for 24 hours to assure saturation. 2 ml of 
the saturated solution were filtered through a 1.0 µm Teflon filter and the solvent 
was evaporated at RT. After dissolving the residue in 0.1 N HCl, the concentration 
of the drug substance was determined by HPLC with a DAD detector at 235 nm and 
analyzed with chromeleon™ 6.7 (Dionex, Sunnyvale, California, USA). A XTerra RP 
18 (20 x 3.5 mm) column was used at a flow rate 1 ml/min and an injected volume 
10 µl. The mobile phase consisted of a phosphate buffer (pH 8.5) and acetonitrile at 
a ratio of 75:25 (v/v). The precision of this method was determined to 0.37%. 
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Table 1:  Solubility parameters, molar volume and solubility for the API in different 
solvents 
Solvent 
δd 
[MPa
1/2
] 
δp 
[MPa
1/2
] 
δh 
[MPa
1/2
] 
Molar volume V1 
[ml/mol] 
API 
Concentration 
[mg/ml] 
2-Propanol 15.8 6.1 16.4 76.8 5.67 
Acetone 15.5 10.4 7.0 74.0 8.89 
Acetonitrile 15.3 18 6.1 52.6 4.35 
Benzyl alcohole 18.4 6.3 13.7 103.6 277.13 
Chloroform 17.8 3.1 5.7 80.7 392.52 
Diethylamine 14.9 2.3 6.1 103.2 3.21 
DMSO 18.4 16.4 10.2 71.3 8.68 
Ethanol 15.8 8.8 19.4 58.5 19.47 
Ethylacetate 15.8 5.3 7.2 98.5 8.82 
Hexanol 15.8 4.3 13.5 124.6 13.63 
Methyl acetate 15.5 7.2 7.6 79.7 10.19 
Methylene chloride 18.2 6.3 6.1 63.9 85.11 
n-Butyl acetate 15.8 3.7 6.3 132.5 6.28 
n-Hexane 14.9 0 0 131.6 0.07 
Pyridine 19.0 8.8 5.9 80.9 110.37 
Tetrahydrofuran 16.8 5.7 8.0 81.7 50.79 
Toluene 18.0 1.4 2.0 106.8 27.88 
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3 Results and Discussion 
3.1 Determination of the solubility parameters  
3.1.1 Experimental determination 
Since experimentally derived Hansen solubility parameters of 3-{2-[4-(6-Fluor-1,2-
benzisoxazol-3-yl)piperidino]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-
a]pyrimidin-4-on could not be found in literature they were determined by own 
measurements. The total and the partial solubility parameters of a substance can be 
calculated from its solubility values in a series of different solvents with known 
cohesive energies [11]. The method is based on the rule that the more similar the 
parameters of two substances are, the better is their miscibility or the solubility of 
one substance in the other. If the parameters match exactly the solubility becomes 
ideal which means that the activity coefficient 2 which is the ratio of the ideal mole 
fraction solubility X2
i and the experimental mole fraction solubility X2 equals 1. In 
terms of total solubility parameters this condition is expressed by equation 2 
 
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where R is the gas constant, T is the temperature at which the experiment is 
performed (K) and 1 is the volume fraction of the solvent. 1 can be expressed as 
follows:  
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with V1 and V2 as the molar volumes of the solvent and the solutes, respectively. In 
all variables the subscript 1 refers to the solvent and the subscript 2 to the solute. 
On the basis of equation (2) Martin and Beerbower developed an extended 
regression model involving Hansen partial solubility parameters [12, 13]. 
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where 1d, 1p, 1h, 2d, 2p, 2h are the partial solubility parameters of the solvent and 
the solute, respectively.  D0 to D3 are constants. Equation 4 can be converted into 
the regression equation 5. 
 
hhppdd
i
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2
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2
1312
2
1102
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)/(
/ln


    (5) 
with 
C0 = D0 + D12d2 + D22p2 + D32h2   (6) 
C1 = D1  (7) 
C2 = -2D12d2  (8) 
C3 = D2 (9) 
C4 = -2D22p2 (10) 
C5 = D3 (11) 
C6 = -2D32h2 (12) 
The constant coefficients C0 to C6 are obtained by regressing the left hand term 
against the partial parameters of the solvents. Bustamante simplified the model by 
proving that the partial solubility parameters can also be obtained by regressing only 
the logarithm of the experimental mole fraction solubility X2 against the partial 
solubility parameters of the solvents [14]. 
h16
2
h15p14
2
p13d12
2
d1102 CCCCCCCXln   (13) 
From equations 6 to 12 the partial solubility parameters 2d, 2p, and 2h are 
calculated as  
δ2d = - (C2 / 2C1) (14) 
δ2p = - (C4 / 2C3) (15) 
δ2h = - (C6 / 2C5) (16) 
As they represent the function’s maximum they can be also obtained from the zero 
points of the partial derivatives lnX2/1(d,p,h). 
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Seventeen different solvents were employed for this study. Their Hansen solubility 
parameters, molar volumes and the experimentally determined saturation 
concentration of 3-{2-[4-(6-Fluor-1,2-benzisoxazol-3-yl)piperidino]ethyl}-2-methyl-
6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-on in each solvent are listed in Table 
1. The following partial solubility parameters of the drug substance were calculated 
from these data: 2d = 18.7 MPa
1/2, 2p = 5.4 MPa
1/2, and 2h = 11.6 MPa
1/2. 
3.1.2 Estimation of the solubility parameters by group contribution 
methods 
As the solubility of a material is largely determined by its chemical nature, the 
solubility parameters can also be calculated from its molecular structure. In this work 
two different approaches were chosen, on the one hand the calculation of the 
solubility parameters according to the group contribution method from Hoftyzer and 
Van Krevelen and on the other hand according to Hoy [15] (Tab. 2).  
Table 2: Comparison of the different parameters contributing to the calculated results of 
the applied methods. 
Hoftyzer and Van Krevelen Hoy 
Experimental 
determination * 
Parameter; 
derived from 
Formula 
Parameter; 
derived from 
Formula 
Parameter; 
derived from 
V 
Calculated 
from 
density 
 V 
Group 
contributio
n tables 
 V Literature 
Fdi 
Group 
contribution 
tables V
FΣ
=δ
di
d  Fti 
Group 
contributio
n tables 
h
2
p
2
t
2
d δ-δ -δ=δ
 
csn 
Experimen-
tally 
determined 
Fpi 
Group 
contribution 
tables 
V
FΣ
=δ
pi
2
p
 
Fpi 
Group 
contributio
n tables 
)
B+F
F*α/1
(*δ=δ
t
p
tp
 
  
Ehi 
Group 
contribution 
tables 
V
EΣ
=δ
hi
h
 
ΔTi 
Group 
contributio
n tables 
)
α
1α
(*δ=δ th    
*) Since the simplified model according to Bustamante et al (1993) [14] was used only the saturation 
solubility (cs) and the molar volume are contributing to the calculation. 
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Method of Hoftyzer and Van Krevelen 
According to Hoftyzer and Van Krevelen the partial solubility parameters can be 
calculated using the following equations: 
 V/Fdid  (17) 
V/F2pip   (18) 
V
Ehi
h

  (19) 
where Fdi and Fpi are the group contributions to the dispersion and the polar 
component (Fd and Fp) of the molar attraction constant, respectively. Ehi is the 
hydrogen bonding energy per structural group in J  mol-1 and V the molar volume of 
the solvent in ml  mol-1. The Hansen partial solubility parameters were calculated as 
d = 20.8 MPa
1/2, p = 6.1 MPa
1/2, and h = 9.2 MPa
1/2.  
 
Method of Hoy 
The procedure of Hoy differs in many respects from the method mentioned before. It 
is based on a molar attraction function (Ft), a polar component (Fp), the molar 
volume of the solute molecule (V), the Lyderson correction for non-ideality (ΔT) and 
auxiliary equations [15].The values obtained by this method are d = 18.0 MPa
1/2, 
p = 12.1 MPa
1/2, and h = 5.1 MPa
1/2 
Only d is within the same range as the experimental value and as calculated 
according to the Hoftyzer/Van Krevelen method whereas p is significantly higher 
and h significantly lower. Tracing back the calculation procedure reveals that h is 
strongly dependent on the molar volume which is calculated in case of Hoy’s 
method also from group contributions. The resulting computed value of 360 cm3/mol 
is much higher than the molar volume of 296.8 cm3/mol found in literature database 
[16] which is identical with the value calculated from the molecular structure (Fig. 1) 
by the software ACD/ChemSketch Freeware (version 10.00, Advanced Chemistry 
Development, Inc., Toronto, ON, Canada, www.acdlabs.com, 2006). If the cohesion 
parameters are recalculated with the lower molar volume the values obtained are 
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d = 19.8 MPa
1/2, p = 13.3 MPa
1/2, and h = 12.6 MPa
1/2, with h matching better the 
experimental value. However p is still higher than determined with the other 
methods. This fact supports the finding that the Hoy procedure does not appear to 
fully separate the polar and hydrogen bonding energies [17]. 
Another set of values was published by Dwan'Isa et al. who computed the cohesion 
parameters using the software Molecular Modeling Pro [18]. These values 
(d = 21.4 MPa
1/2, p = 6.9 MPa
1/2, and h = 9.5 MPa
1/2) are very close to those 
obtained with the Hoftyzer/Van Krevelen method and are most likely calculated by 
the same algorithm 
 
Figure 1: Molecular structure of 3-{2-[4-(6-Fluor-1,2- benzisoxazol-3-yl) piperidino]ethyl}- 2-
methyl-6,7,8,9- tetrahydro-4H-pyrido [1,2-a]pyrimidin-4-on 
On the whole, the experimentally determined values are within a similar range as 
those calculated by group contribution procedures (with the exception of p 
according to Hoy) (Tab. 3).  
Table 3: Experimentally obtained and calculated partial solubility parameters  
  
δd 
 [MPa1/2] 
δp 
 [MPa1/2] 
δh 
[MPa1/2] 
Experimental results 18.7 5.4 11.6 
Calculated values (Hoftyzer, Van Krevelen) 20.8 6.1 9.2 
Calculated values (Hoy) 19.8 13.3 12.9 
Value derived from literature *) 21.4 6.9 9.5 
*)
 Dwan’Isa et al., 2005 [18] 
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Nevertheless they are considered more reliable than those derived from molecular 
structure elements on the basis of empirical rules. Especially the calculated values 
for d are extremely high and contrary to the measured solubility in less lipophilic 
solvents. Thus, for further considerations, only the experimental results were used. 
3.2 Estimation of the solubility of the drug substance in different 
solvents and in PLGA 
Partial solubility parameters are often represented in a three-dimensional grid, the 
so-called Hansen space. The mutual miscibility of two substances or the solubility of 
one substance within the other can be estimated from their relative coordinate 
positions, i.e. the Euclidean distance between both coordinate points. The smaller 
the distance in the diagram, the better is the mutual solubility between the two 
substances. Figure 2 shows the coordinate positions of the solvents listed in Table 1 
and the coordinate points of the API calculated by different methods.  
In such diagrams solvents and low molecular molecules are commonly depicted as 
single coordinate points whereas polymers are drawn as volume structures, mostly 
spheres. They enclose the diagram range in which solvents with good solving or 
swelling properties for the polymer are located.  
Schenderlein et al. used two different experimental methods and a group 
contribution approach to determine the center point and the interaction radius of the 
solubility sphere of PLGA (75:25) [19]. The following values are reported, differing 
especially with respect to δp: Swelling experiments (δd = 17.4 MPa
1/2, 
δp = 8.3 MPa
1/2, δh = 9.9 MPa
1/2), turbidity titration (δd = 15.8 MPa
1/2, 
δp = 3.5 MPa
1/2, δh = 9.1 MPa
1/2) and group contribution method (δd = 16.1 MPa
1/2, 
δp = 9.7 MPa1/2, δh = 11.7 MPa
1/2). The interaction radius which was only 
determined by polymer swelling amounts to 7.8 MPa1/2. 
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Figure 2:  Position of on the drug substance (calculated and experimentally determined) and the 
tested solvents (Tab. 1) in a three dimensional diagram  
As the experimental determination is considered to be more accurate than 
predictions from the molecular structure and the data obtained from swelling 
measurements are the most comprehensive for they provide also an interaction 
radius of the sphere, only these values were used for further calculations (Fig. 3). 
The coordinate position of a substance with respect to a polymer solubility sphere is 
characterized by the ratio of the coordinates’ distance to the centre of the sphere 
and the sphere’s interaction radius. This ratio is called the Relative Energy 
Difference (RED) [20]. A RED less than 1.0 indicates a high affinity or solubility 
(coordinate position within the sphere), a RED higher than 1.0 lower affinities to the 
polymer (coordinate position outside the sphere) (Fig. 4). 
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Figure 3: Solubility sphere of PLGA (75:25) and the position of the solvents (● = outside the 
sphere, o = inside the sphere) and on the drug substance (▲) in the δd – δp – δh-
diagram 
 
Figure 4: Relative Energy Difference between PLGA (75:25) and the analyzed solvents and 
the API, respectively 
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The distance between two coordinate points within the Hansen space D(S-P) is 
calculated by the following equation [20]:  
       2/1222)( 4 pspspsD hhppddPS    (20) 
From the experimentally determined solubility parameters of the API and the center 
coordinates of the PLGA 75:25 solubility sphere taken from literature (swelling data 
from Schenderlein et al. [19]) a distance of 5.05 and a RED of 0.61 was calculated, 
which implies that the drug substance lies inside the sphere and should be soluble 
in the polymer to a certain extent. 
The true solubility within a polymer matrix, unbiased by depositions of unsolved 
crystalline or amorphous substance, is hardly accessible by direct chemical 
analysis. A mathematical approach was made by calculating the solubility in the 
polymer matrix based on the regression equation 13. After δ2d, δ2p, and δ2h and the 
coefficients C0 to C6 are calculated they can be inserted in equation 13 together with 
the polymer’s δ1d, δ1p, and δ1h to obtain X2 as the solubility of on the drug substance 
in PLGA. The conversion of the mole fraction solubility into a weight/weight 
concentration was done on basis of the average molecular weight of a repetitive 
monomer unit of PLGA (75:25) (68.6 g/mol). By this method X2 was computed as 
0.0235. This corresponds to 0.144 g API per g PLGA, which is a drug load of 12.6% 
(w/w) in the drug/PLGA mixture.  
In order to demonstrate the plausibility of these results, a second approach was 
tried based on differential scanning calorimetry. Microparticles with different degree 
of drug load as well as physical API / PLGA mixtures (0%, 30.9%, 49.3%, 81.8% 
and 100%) were measured and the enthalpy of fusion was calculated from the 
melting peak of the drug. A linear correlation could be established between the 
enthalpy of fusion and the drug concentration in the mixtures. Also in case of the 
microparticles a linear correlation function was found with almost the same slope but 
enthalpies being between 14 and 21 J/g lower than those of the mixtures with a 
corresponding drug amount. This can be explained by the fact that the drug, which 
is dissolved in the polymer, is not in a crystalline state and does not contribute to the 
enthalpy of fusion. The same applies to amorphous drug which is finely dispersed 
between the polymer chains and thus protected against recrystallization. From the 
offset between the correlation curves, we could calculate a fraction of 13-16% on 
the API dissolved in the polymer matrix. Taking into consideration that both, the 
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theoretical approach as well as the DSC measurements are afflicted with a certain 
error, the results are within the same range. 
3.3 Prediction of drug-polymer-interactions during processing 
based on solubility parameters and effects on the properties 
of the resulting microspheres 
For the microparticle preparation process three sets of solubility parameters (for the 
drug, the polymer and the solvent or solvent mixture) have to be considered. It is 
essential, that the drug substance and the polymer are soluble in the solvent of the 
dispersed phase. On the other hand the solvent should be soluble in the aqueous 
phase to some degree and extractable from the droplets to induce microparticle 
solidification. The solvent has to be chosen, to meet both criteria. 
In pure methylene chloride the polymer and the drug substance show almost the 
same solubility. The distance calculated by Eq. 20 between drug substance and 
methylene chloride is 5.46 MPa1/2 and between PLGA and methylene chloride it is 
5.51 MPa1/2. The solubility of both was varied by adding different co-solvents in the 
process. A fraction of methylene chloride was substituted by a better or a poorer 
solvent for the drug in order to modifiy the drug distribution in the polymeric phase 
and the degree of crystallization during the manufacturing process. This is 
influenced by the drug’s solid state solubility [21], which in turn has an impact on the 
release behaviour of the resulting microspheres. Solid dispersions of poorly water 
soluble drugs are often used to enhance the drug dissolution and bioavailability [22, 
23]. In case of a long acting dosage form a low solubility and a crystalline state of 
the drug is desirable.  
Minghetti et al found, that the release rate of the solved drug was most quickly, 
when the difference between the solubility parameter of the drug and the polymer 
matrix was highest due to the maximum thermodynamic activity of the drug 
substance [24]. 
Furthermore co-solvents have been reported to influence the partitioning of the 
organic phase into the external phase and thus to affect for example drug load and 
release kinetics of the microspheres [25]. 
In the present study we investigated the impact of binary solvent mixtures on the 
properties of the resulting microspheres. Methylene chloride was used as the basic 
component in the organic phase, as it is a common solvent for the preparation of 
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PLGA microspheres with the advantage of simple removal by extraction and 
evaporation. Benzyl alcohol was added in various concentrations to enhance the 
dissolving power for the drug substance, whereas n-butanol was used to cause the 
opposite effect. 
Consequently, microparticles were prepared with 10%/90% and 25%/75% mixtures 
of benzyl alcohol and methylene chloride (Tab. 4) and with a 25%/75% mixture of n-
butanol and methylene chloride. With all solvent mixtures spherical, nonaggregated 
microparticles were obtained. However the particles prepared with 25% benzyl 
alcohol and n-butanol were not stable during storage at room temperature and 
agglomerated by and by.  
The partial solubility parameters of benzyl alcohol differ from those of methylene 
chloride especially in their hydrogen bonding component. Benzyl alcohol has a 
lower h and is a better solvent for the API. As both solvents are only poorly soluble 
in water with solubilities being in about the same range (benzyl alcohol: 3.9% (m/v), 
methylene chloride: 2.0% (m/v)) it can be assumed that the extraction process is 
mainly governed by different evaporation rates. 
Table 4: Influence of the solvent mixture on encapsulation efficiency and drug release 
rate 
 
Ratio 
(w/w) 
Ratio 
(v/v) 
Encapsulation 
efficiency [%] 
Drug 
released 
after 25 d [%] 
Methylene chloride   83.6 40.2 
Methylene chloride : Benzyl alcohol 90:10 88:12 85.0 52.0 
Methylene chloride : Benzyl alcohol 75:25 70:30 82.9 33.8 
Methylene chloride : n-Butanol 75:25 65:35 80.5 51.5 
As methylene chloride (b.p. 39.8 °C) is more volatile than benzyl alcohol 
(b.p. 205 °C), it evaporates faster, thus shifting of the solvent ratio inside the 
particles (Fig. 5). It can be seen that if the process starts with a benzyl alcohol / 
methylene chloride ratio of 10:90 or 25:75 the solubility of the polymer in the solvent 
mixture, expressed as the coordinate distance in the Hansen space, decreases 
whereas the solubility of on the API increases during evaporation of methylene 
chloride. Even though the drug again becomes a little bit less soluble toward the end 
of the process this does not change the fact that there is a net improvement of the 
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drug’s solubility after complete removal of methylene chloride. These contrasting 
changes in solubility, i.e. deterioration in case of PLGA and improvement in case of 
the drug, support a rapid hardening of the particles and an effective retention of the 
drug in the particles. At least in case of a 10:90 solvent mixture, causing a 2.6 
MPa1/2 net reduction of the drug-solvent coordinate distance during the process, 
improved encapsulation efficiency could be found in comparison to particles 
prepared with pure methylene chloride. Only a marginal change of the 
encapsulation efficiency even in the opposite direction was observed with a 25:75 
mixture which is in a certain correlation to the much smaller intra-process distance 
change of only about 1 MPa1/2. A fraction of more than 25% benzyl alcohol in the 
organic phase is not beneficial because multinucleated particles are formed the 
product is not stable and agglomerates during storage. Furthermore a high content 
of residual benzyl alcohol is undesirable with regard to toxicological aspects. 
 
Figure 5: Distance between polymer (-■-) and API (-▲-) and solvent mixture with varying fraction 
(v/v) of benzyl alcohol.  
As a second solvent for the preparation of the microspheres, a 25:75 n-butanol / 
methylene chloride mixture was employed. n-Butanol differs in its dispersion forces 
and hydrogen bonding component from methylene chloride and has only a low 
dissolving power for the API. As n-butanol (b.p. 117.7 °C) is also less volatile than 
methylene chloride the same consideration as for benzyl alcohol and methylene 
  CHAPTER 2 
 
39 
chloride can be made (Fig. 6). The solubility of the polymer is higher in n-butanol 
than in methylene chloride with a local maximum at a 60:40-mixture. It is much 
better than in benzyl alcohol / methylene chloride mixtures. By contrast, the 
solubility of the drug substance is poorer and decreases strongly from 100% 
methylene chloride to 100% n-butanol. Consequently a lower retention of the drug 
has to be expected and was confirmed by an encapsulation rate 3.1% lower than in 
case of a pure methylene chloride process. 
 
Figure 6: Distance between polymer (-■-) and API (-▲-) and solvent mixture with varying fraction 
(v/v) of n-butanol.  
Apart from the effect on the encapsulation efficiency the solvent was found to 
influence also the morphology of the drug. X-ray diffraction demonstrates that in 
contrast to methylene chloride or its mixtures with benzyl alcohol (data not shown), 
which lead to a certain amount of crystalline drug, the n-butanol / methylene chloride 
mixture caused deposition of the drug in a totally amorphous form (Fig. 7). 
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Figure 7: X-ray diffractogram of microspheres prepared with methylene chloride (top) and 
 with a mixture of methylene chloride and n-butanol (75:25)  (bottom) 
When the concentration of n-butanol rises during the process as described above 
and thus the solubility of the drug substance in the solvent mixture inside the 
microspheres decreases, the partition of the drug between solvent regions and 
polymeric phase shifts in favour of the latter. Because the polymer acts as a 
crystallization inhibitor the drug will not precipitate in a crystalline but in an 
amorphous state. In solid dosage forms normally the most stable polymorph of a 
drug substance is preferred, as an amorphous drug substance is thermodynamically 
less stable and tends to undergo uncontrollable alterations during storage [26]. 
Surprisingly, in case of the studied microspheres the presence of amorphous API 
had about no influence on the drug release profile (Fig. 8). Regarding the drug 
release of the microspheres prepared with benzyl alcohol and methylene chloride 
also no influence could be shown. All curves were within the variation limits obtained 
with different batches from a pure methylene chloride process. 
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Figure 8: Drug release of microspheres prepared with different organic solvents: methylene 
chloride (-▲-), methylene chloride / n-butanol 75:25 (w/w) (-□-), benzyl alcohol / 
methylene chloride 75:25 (w/w) (-■-) and 90:10 (w/w) (-♦-) 
It could be shown by DSC measurements that already on the second day of the 
release test the amorphous fraction had disappeared and a recrystallization peak 
could not be observed anymore. This indicates that the morphological state of the 
embedded drug is irrelevant for the release kinetics because recrystallization occurs 
upon the first contact with water and subsequently the drug is always released from 
a crystalline solid. Thus any potential recrystallization during storage is not likely to 
have a major impact on drug release.  
4 Conclusions 
The partial solubility parameters of 3-{2-[4-(6-Fluor-1,2-benzisoxazol-3-yl) 
piperidino]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-on were 
determined by three different methods, of which the experimental approach appears 
to provide the most reliable values. The structure of this drug substance is rather 
complex for the calculation by group contribution methods. For some structural 
elements of the molecule no values are tabulated. From the solubility parameters of 
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on the API and of PLGA a fraction of 12.6% of the drug was calculated to be 
dissolved in the polymer matrix. This order of magnitude could also be verified by 
DSC measurements.  
Methylene chloride is one of the most commonly used solvents for the preparation 
of PLGA microspheres by emulsion-solvent evaporation. It is highly volatile and 
easily extractable from the microspheres. On the basis of partial solubility 
parameters two co-solvents were chosen as additional solvent components. Benzyl 
alcohol was selected as it enhances and n-butanol as it diminishes the dissolving 
power for the drug substance. Three different co-solvent / methylene chloride 
mixtures were analyzed with regard to their particle characteristics and drug release 
behaviour. The encapsulation efficiency was slightly increased if the drug became 
better soluble in the solvent mixture during the process and it was diminished if the 
extraction process led to a mixture with a lower dissolving power for the drug. 
Moreover, the solvent selection showed an influence on the morphology of the drug 
and it could be shown, that the addition of n-butanol caused an almost completely 
amorphous state of the API. It is remarkable, that these particles produced nearly 
the same drug release profile as particles, which contained the drug in a crystalline 
state. Recrystallization upon the first contact with dissolution medium was found to 
be the reason for this behaviour. Thus, microspheres which contain the drug or 
fractions of the drug in an amorphous state are not to be considered as prone to 
instabilities influencing the drug release kinetics.  
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CHAPTER 3 
 
Control of the droplet size of the primary emulsion 
in a solvent removal process 
Abstract 
In an emulsion solvent removal process for the preparation of PLGA microspheres 
the particle size can be affected at various stages in the process. First of all the 
particle size depends on the droplet size of the primary emulsion injected into the 
preparation vessel and can subsequently change during extraction of the solvent 
from the droplets and transformation into solid particles. 
The primary emulsion was prepared using a static mixer. Thereby the effects of 
three factors on the droplet formation were studied: the pump rate of organic and 
aqueous phases as well as the application of different numbers of flow obstacles 
(mixing elements) in the static mixer. The test series was set up by a factorial design 
as this is an efficient way to study the influence of several process parameters in 
parallel. By illustrating the relationship between process parameters and obtained 
droplet size the optimum process parameters to obtain a desired droplet size could 
be easily determined.  
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1 Introduction 
The particle size is of vital importance for various attributes of microparticulate 
carrier systems. In case of biodegradable microparticles for injection the particle 
size is primarily important for their suspensibility and syringeability [1]. Furthermore 
it influences the in vivo degradation, the drug release kinetics and phenomena like 
the particle uptake by phagocytic cells. Thus, the control and monitoring of the 
particle size is necessary to ensure the production of microparticles with desired 
properties. 
In case of a solvent removal process the particle size can be influenced at different 
stages of the process. The first step in this process is the preparation of a primary 
emulsion from an organic solution of drug and polymer and an aqueous phase. At 
this stage of the process the original droplet size is defined. The emulsion can be 
prepared by a variety of methods, including stirring, static mixing, homogenization, 
sonication and microfluidization [2-4]. Depending on the applied emulsification 
method the droplet size can be affected by a variety of formulation parameters like 
mixer/stirrer geometry, ratio of organic and aqueous phase volume, temperature or 
polymer concentration among others, which may cause problems in process scale 
up. In this context, the utilization of a static mixer is advantageous as for scale up 
several mixers can be used in parallel flow [5, 6] and mathematical extrapolation of 
the flow rates to larger mixer dimensions is possible [7]. Furthermore, a kinetically 
stable primary emulsion will only be obtained in the presence of a stabilizer, 
commonly polyvinyl alcohol. The type and concentration of the stabilizer affects the 
particle size, shape and the drug encapsulation efficiency [8-10]. This primary 
emulsion is subsequently added to a large surplus of aqueous phase and stirred to 
allow extraction and, in case of volatile organic solvents, evaporation of the organic 
solvent. Throughout this extraction phase and hardening of the droplets to solid 
particles, size changes can occur. Moreover the emulsion droplets in one single 
process will show different hardening and result in microparticles with varying 
characteristics. Whereas the emulsion droplets from the beginning of the process 
are fed into fresh extraction medium, the droplets from the end come in contact with 
extraction medium already containing a certain amount of organic solvent.  
In this work the size control during droplet formation using a static mixer was 
studied. The effects of three factors on the droplet size in the primary emulsion were 
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studied: the pump rate of organic and aqueous phase as well as the application of 
different numbers of flow obstacles in the static mixer. 
2 Materials and methods 
2.1 Materials 
Poly(D,L-lactide-co-glycolide) 75:25 (Resomer 755 S, Mw = 64710 Da) was 
purchased from Boehringer Ingelheim (Ingelheim, Germany). Methylene chloride 
analytical grade was obtained from Merck (Darmstadt, Germany), and TRIS 
(Tris(hydroxymethyl)-aminomethan) from AppliChem (Darmstadt, Germany). 3-{2-
[4-(6-fluor-1,2-benzisoxazol-3-yl)piperidono]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-
pyrido[1,2-a]pyrimidin-4-on was purchased from Jubilant Organosys (Mysore, India) 
and polyvinylalcohol PVA 18-88 (PVA) from Kuraray Europe GmbH (Frankfurt, 
Germany). 
2.2 Determination of the droplet size – single particle optical 
sizing (SPOS) 
The droplet size distribution was determined by single particle optical sizing (SPOS) 
with an Accusizer 780 particle sizing system, Sensor: LE400-05SE (Particle Sizing 
Systems, Santa Barbara, CA). This instrument uses the principle of light obscuration 
to count and size particles from 0.5 to 400 µm. The data are collected in 512 
logarithmically spaced channels with a minimum and maximum fraction width of 1 to 
5.54 µm. The primary emulsion was measured without further treatment or dilution 
promptly after emulsion preparation to prevent hardening of the droplets by 
evaporation of methylene chloride. To ensure a uniform emulsion, the sample was 
stirred with a magnetic stirrer. 50 ml of the suspension were analyzed per 
measurement.  
2.3 Formation of the primary emulsion 
The primary emulsion was formed from an organic phase, consisting of a solution of 
2.8 g 3-{2-[4-(6-fluor-1,2-benzisoxazol-3-yl)piperidono]ethyl}-2-methyl-6,7,8,9-
tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-on and 3.2 g PLGA 75:25 in 40 mL 
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methylene chloride and 500 mL of an aqueous solution of 0.5% (w/v) PVA and 
0.1 M Tris buffer (pH 9.0). Both phases were pumped (with a gear pump MCP-Z 
Process, Ismatec IDEX Health & Science GmbH, Wertheim-Mondfeld equipped with 
Coriolis-massflowmeters, Sitrans FC Massflo, Siemens AG, Wien, Austria) through 
a static mixer (Sulzer mixer with SMXE mixing elements, Sulzer Chemtech AG, 
Winterthur, Switzerland) containing a variable number of mixing elements. The 
pump rate of the organic phase was varied between 10 and 14 g/min, the flow rate 
of the aqueous phase between 60 and 80 g/min, and the number of mixing elements 
from 0 to 4. The utilized mixing elements have a size of 6x6 mm and are arranged 
end-to-end in a pipe of 60 mm length. The primary emulsion was taken directly from 
the outlet of the mixer and analyzed by SPOS. 
The set-up of the test series was made by Design of Experiments using the software 
MODDE (Version 9.0.0.0 from Umetrics AB, Umeå, Sweden) [11]. 
3 Results and discussion 
Design of Experiments is a time and cost saving way for screening, optimization and 
robustness testing of preparation processes. Especially in a microparticle 
preparation process where many variables have an influence on the resulting 
product, a statistical experimental design is beneficial [12-14]. It can also be applied 
on the preparation of the emulsion in a microparticle preparation process [15]. In 
order to simplify up scaling, the organic phase was dispersed in the continuous 
phase by the application of a static mixer (Fig. 1). The static mixer consists of a tube 
with integrated flow obstacles (mixing elements), which, in the laminar operation 
mode, cause splitting up and recombining of the fluid streams. Thus the average 
droplet size is achieved when the equilibrium between droplet break up and 
coalescence is reached [16]. If the geometry of the mixing elements and the 
composition of the organic and continuous phase are not changed and the 
experiments are performed at room temperature, there are mainly 3 factors 
influencing the resulting droplet size: flow rate of the aqueous phase, flow rate of the 
organic phase and the number of mixing elements.  
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Figure 1: Static mixer with SMXE mixing elements 
With a central composite face-centered (CCF) design the three factors and their 
interactions were investigated. In the CCF design the experimental region is a cube, 
with the axial points centered on the faces of the cube (Fig. 2). The CCF design with 
3 variable factors is based on 14 experiments and three replicated center-points, 
which are performed in randomized order (Tab. 1). 
 
 
Figure 2: The CCF design in three factors 
The resulting droplet size of the primary emulsion as determined by SPOS ranged 
between approx. 50 and 130 µm and is provided in Table 1. 
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Table 1:  Experimental set up of the CCF design study  
 Factor 1 Factor 2 Factor 3 Response 
Run 
order 
Flow rate 
aqueous phase 
[g/min] 
Flow rate 
organic phase 
[g/min] 
Number of mixing 
elements 
Droplet size * 
[µm] 
8 60 10 0 132.1 
9 80 10 0 110.9 
10 60 14 0 105.8 
11 80 14 0 85.3 
23 60 10 4 78.0 
24 80 10 4 93.3 
15 60 14 4 59.6 
16 80 14 4 56.2 
3 60 12 2 55.1 
4 80 12 2 73.8 
5 70 10 2 97.2 
6 70 14 2 52.6 
12 70 12 0 103.7 
17 70 12 4 59.0 
1 70 12 2 85.0 
2 70 12 2 80.1 
7 70 12 2 63.1 
* volume weighted median 
The experimental data were investigated using regression analysis with a quadratic 
model. The coefficient plot was obtained by correlating the changes in the factors to 
the changes in the response (Fig. 3). The error bars of only two factors, the flow rate 
of the organic phase and the number of mixing elements, do not cross the x-axis 
indicating a significant impact. The flow rate of the aqueous phase has no significant 
influence in the examined range of 60 to 80 g/min. Furthermore, there is no 
significant interaction between the individual factors influencing the particle size. 
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The not significant interactions of the factors were therefore eliminated from the 
model and the regression analysis was re-calculated.  
 
Figure 3: Effects of the flow rates of aqueous phase (FRaq), and organic phase (FRor) and 
number of mixing elements (No) as well as their interactions on the resulting droplet size 
Additionally, the results were converted into response contour plots (Fig. 4). The 
models show, that the droplet size decreases with an increasing number of mixing 
elements. At constant flow rates of 70 g/min for the aqueous phase and 12 g/min for 
the organic phase the droplet size decreases from 103.7 µm without mixing 
elements to 80.1 µm for 2 and finally 59.0 µm for 4 mixing elements. Such an 
inverse correlation was also found by Theron et al. [16]. 
Without the utilization of mixing elements the droplet size is determined only by the 
flow rates of the phases. By increasing the overall flow rates of both phases at a 
constant ratio smaller droplet sizes are obtained. This effect is diminished by an 
increasing number of mixing elements. Whereas the flow rate of the aqueous phase 
itself has no significant impact on the droplet size, the resulting droplet size is 
significantly influenced by the flow rate of the organic phase. Increasing flow rate of 
CHAPTER 3                                                                                                                                                
54 
the latter reduces the resulting droplet size. Without utilization of mixing elements 
and at a constant flow rate of 60 g/min for the aqueous phase the resulting droplet 
size decreases from 132.1 µm at 10 g/min to 105.8 µm at 14 g/min.  This effect is 
less pronounced the higher the number of mixing elements. With 4 mixing elements 
the droplet size varies only from 78 µm to 59.6 µm.  First of all a higher number of 
mixing elements increases the efficiency of splitting and recombining the fluid 
streams leading to smaller emulsion droplets at lower flow rates. However, when 
using 4 mixing elements instead of 2 the droplet size reduction becomes less 
pronounced. 
 
Figure 4:  Response contour plot of the flow rates of organic and aqueous phase: (a) without 
mixing elements, (b) with 2 mixing elements and (c) with 4 mixing elements 
The data can also be used to define the parameters necessary to achieve a certain 
droplet size as illustrated in Figure 5. In this study the target droplet size was 
between 50 to 60 µm. In fast particle forming processes the particles will show a log 
normal distribution, which can therefore also be expected for the emulsion solvent 
removal process. Thus a particle size distribution with a median diameter of 60 µm 
will range approximately from 30 to 150 µm, which allows a good injectability and 
syringeability with a standard injection needle [17].  
The grey region in the Sweet spot plot indicates the process parameters for the 
desired droplet size between 50 and 60 µm. This target droplet size cannot be 
achieved without using mixing elements with the applied flow rates. Only with 2 or 4 
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mixing elements droplets smaller than 60 µm can be achieved. By using only 2 
mixing elements high flow rates have to be applied to obtain a fine dispersion with 
the desired droplet size. By applying 4 mixing elements this small droplet size can 
also be obtained at lower velocities of the phases. Over the whole range of 60 to 80 
g/min for the aqueous phase and in a range of 11.5 to 14 g/min for the organic 
phase a droplet size between 50 and 60 µm should be achieved. 
 
Figure 5: „Sweet spot plot“ for a desired droplet size between 50 to 60 µm  
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4 Conclusion 
With regard to the commercial production of a microparticulate dosage form by the 
emulsion solvent evaporation technique one critical step especially for the up-scale 
of the process is the preparation of the primary emulsion droplets. The droplet size 
is an important factor for the particle size of the resulting microspheres. To 
investigate, which droplet size will be achieved under certain process parameters, 
“Design of Experiments” is a versatile tool. With a minimum number of experiments 
the flow rates and number of static mixing elements can be determined, which are 
necessary to obtain an appropriate droplet size. 
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CHAPTER 4 
Understanding reflection behavior as a key for 
interpreting complex signals in FBRM monitoring 
of microparticle preparation processes ‡ 
 
Abstract 
The application of focused beam reflectance measurement (FBRM) was studied in a 
larger scale PLGA microparticle preparation process for monitoring changes of the 
particle size and the particles’ surface properties. Further understanding how these 
parameters determine the chord length distribution (CLD) was gained by means of 
single object measurements and data of monodisperse microparticles. It was 
evaluated how the FBRM signal is influenced by the surface characteristics of the 
tested materials and the measuring conditions. Particles with good scattering 
properties provided comparable values for the CLD and the particle size distribution. 
Translucent particles caused an overestimation of the particle size by FBRM, 
whereas the values for transparent emulsion droplets were too low. Despite a strong 
dependence of FBRM results on the optical properties of the samples, it is a 
beneficial technique for online monitoring of microparticle preparation processes. 
The study demonstrated how changing reflection properties can be used to monitor 
structural changes during the solidification of emulsion droplets and to detect 
process instabilities by FBRM.  
 
 
‡ 
Published in International Journal of Pharmaceutics, 2012, 437 (1-2), p. 1-10: Vay,K.; Friess,W.; 
Scheler,S. Understanding reflection behavior as a key for interpreting complex signals in FBRM 
monitoring of microparticle preparation processes. 
CHAPTER 4                                                                                                                                                
 60 
1 Introduction 
Since the launch of the PAT initiative by the American Food and Drug 
Administration (FDA) in 2002 in-process measuring methods have become more 
and more important for manufacturers of pharmaceuticals. The PAT strategy relies 
on a thorough understanding of the whole manufacturing process and requires 
predictive relationships between product properties during intermediate process 
steps and the final product quality. Thus online monitoring methods have become 
increasingly interesting.  
In case of the preparation of biodegradable polymeric microspheres for sustained 
drug release, the particle size is a decisive factor for their release behaviour [1, 2]. If 
such particles are prepared by an emulsion/solvent removal process the size of the 
resulting microspheres is determined by the droplet diameter of the primary 
emulsion. In the course of further processing the droplet size undergoes secondary 
changes which depend, via various mechanisms, on the process parameters of the 
solvent extraction/evaporation step, for example the stirring rate [3-5]. At-line 
measurements of the microsphere or droplet size are usually accomplished with 
laser-based particle size analyzers [6, 7] or the coulter principle [8, 9]. 
An ideal technique for in-process monitoring of manufacturing process should be 
non-destructive and fast enough to allow real-time tracking of the particle or droplet 
size, respectively. There are several particle sizing methods for in- and online 
applications based, for example, on laser diffraction [10], ultrasonic attenuation 
spectroscopy or phase Doppler anemometry [13]. A preferably used technique for 
process monitoring is the focused beam reflectance measurement (FBRM) [14]. An 
advantage of this measuring principle is the large particle size range from 1 to 
approximately 4000 µm depending on the rotating speed of the laser beam. Core 
piece is a probe, emitting a rotating laser beam, which is mounted in a pipe or 
dipped into a stirred medium. The laser beam with a wavelength of 780 nm revolves 
with high velocity of 2 m/sec to 8 m/sec depending on the chosen mode, so that the 
particles’ own motion is negligible. When the focus of the laser beam passes a 
particle, the light is scattered back to the probe window, where the detector is 
located. The signal is processed by a discrimination circuit with a selectable 
threshold level. A chord length is calculated from the period during which the light is 
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backscattered to the detector and the speed of the revolving laser beam. Because 
the radius of the beam’s revolution is much larger than the particle diameter, the 
chord length can be approximated by the length of a straight line between the two 
points at which the laser beam randomly intersects the boundary line of the 
particle’s projected area. The FBRM is applicable within a wide concentration or 
viscosity range and, as up to 100000 chord lengths are measured per second, 
statistically robust chord length distributions (CLD) are obtained. However such 
CLDs are difficult to compare with results of common particle sizing methods 
because they represent a superimposition of the size distribution of all measured 
particles and the lengths distribution of all possible chord lengths of each single 
particle. For example, from monodisperse spheres a chord length distribution can be 
obtained for which the probability Pk(x) of a chord to lie within an interval from x-w to 
x+w is  
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with Dk being the sphere diameter. In a polydisperse particle distribution Dk is the 
middle of the kth diameter band and w is half the width of the diameter band. The 
total number of chord size detections at a certain size x (n(x)) is the sum of the 
probability-weighted number of particles in the kth diameter band (nk): 
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k is the number of bands into which the size range is divided. In order to restore the 
particle size distribution (PSD) from the CLD the equation has to be solved for nk. 
Several methods are available to accomplish this. Calculation is easiest in case of 
spherical particles. However, if the particle geometry is known it is often possible to 
convert also CLDs from non-spherical particles into PSDs. This transformation has 
been subject of several studies [15-17]. 
Typical applications of FBRM are process optimization, control of crystallization 
processes [18, 19], polymorphic transformations [20, 21] or the characterization of 
plant suspension cultures [22]. Furthermore several studies using the FBRM for 
investigation of emulsion systems [23, 24] were published. 
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In many of these applications the signal pattern measured by FBRM does not only 
reflect the geometric characteristics of a CLD as explained above but is strongly 
biased by additional factors. Especially in case of emulsion droplets and other 
smooth or transparent particles a marked effect of reflection phenomena becomes 
apparent. In many cases FBRM data are more dependent on the particles’ optical 
properties than those of other particle sizing methods [25]. However most of the 
previous studies failed to consider these effects. This is also true for the so far only 
study which describes the use of FBRM in order to monitor a solvent extraction 
process for microparticle preparation [14]. Our work also addresses the application 
of FBRM in a solvent removal process but puts special emphasis on reflection 
phenomena affecting the measurement. Deeper knowledge of this issue could 
broaden the field of possible applications and help to avoid misinterpretations. The 
study also investigates how this technique can be used in order to monitor 
alterations of the particles’ surface and the interior of transparent particles even if 
they do not involve any changes of size or shape. 
2 Materials and methods 
2.1  Materials 
Transparent polystyrene research particles (98.7 ± 1 µm) and black polystyrene 
microspheres (103.9 µm) were obtained from Microparticles GmbH (Berlin, 
Germany).  
Poly (D,L-lactide-co-glycolide) 75:25 (Resomer 755 S): Mw = 64710 Da was 
purchased from Boehringer Ingelheim, (Ingelheim, Germany). Methylene chloride 
analytical grade was obtained from Merck (Darmstadt, Germany), and TRIS 
(Tris(hydroxymethyl)-aminomethan) from AppliChem (Darmstadt, Germany). 3-{2-
[4-(6-fluor-1,2-benzisoxazol-3-yl)piperidono]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-
pyrido[1,2-a]pyrimidin-4-on was purchased from Jubilant Organosys (Mysore, India) 
and PVA 18-88 from Kuraray Europe GmbH (Frakfurt, Germany). 
2.2 Microparticle preparation 
Plain microparticles were prepared by an emulsification solvent 
extraction/evaporation technique. 4.8 g PLGA were dissolved in 46.1 g of methylene 
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chloride and the solution was emulsified in 500 ml of the extraction medium 
consisting of an aqueous solution of 0.5% (w/v) povidon and 0.1 M Tris buffer 
(pH 9.0). For the purpose of the droplet size measurements this emulsion was 
pumped through a flow through cell. 
Microparticle preparation started with feeding the emulsion into a 5 L jacketed glass 
reactor containing 3.5 L of the aqueous phase. By stirring for 5 hours the droplets 
were hardened by solvent extraction and evaporation with an air flow through the 
headspace of the reactor, which was exactly controlled by a mass flow meter 
(Vögtlin instruments AG, Aesch, Switzerland). The obtained particles were 
separated by filtration and dried under vacuum in a desiccator. Different particle 
batches were produced by varying the extraction temperature between 10 and 
35 °C, the air flow through the reactor from 5 to 20 L/min, the stirring speed from 
120 to 260 rpm and by adding 0.6% solvent to the aqueous extraction phase. In the 
same way microparticles containing API were prepared by dissolving 2.8 g 3-{2-[4-
(6-fluor-1,2-benzisoxazol-3-yl)piperidono]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-
pyrido[1,2-a]pyrimidin-4-on and 3.2 g PLGA in 46.1 g of methylene chloride. 
2.3 Methods 
2.3.1 Focused beam reflectance measurement 
The FBRM measurements were performed using a Lasentec® D600 FBRM system 
with a probe for laboratory use (Mettler-Toledo AutoChem, Inc., Redmond, USA). 
At-line measurements were made at a stirring speed of 400 rpm in a glass beaker 
using the fixed beaker stand which is an accessory part of the Lasentec® 
instrument. For this purpose the microparticles were suspended in an aqueous 
solution of polysorbate 80 (approximately 150 ml) and measured over 5 minutes. 
For process monitoring purposes the probe was inserted through the top of the 
reactor into the stirred suspension (stirring speed 260 rpm), so that the angle of 
incidence was between 30 to 60°, and the flow was directed obliquely towards the 
window surface. All measurements were performed using the fine discrimination 
mode and the default focus position was -20 µm. The FBRM system counts the 
number of detected chords per second in each size fraction.  
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2.3.2 Single particle optical sizing (SPOS) 
The particle size distributions of polystyrene and PLGA microparticles were 
additionally measured with an AccuSizer 780 particle size analyzer (Sensor: LE400-
05SE; Particle Sizing Systems, Santa Barbara, CA). This instrument uses the 
principle of light obscuration to count and size particles from 0.5 to 400 µm (single 
particle optical sensing, SPOS). The data are collected in 512 logarithmically 
spaced channels with a minimum and maximum fraction width of 1 to 5.54 µm. 
Approximately 20 mg of particles were weighed in a sample vessel and suspended 
in 100 ml of an aqueous solution of polysorbate 80. To ensure a uniform 
suspension, the sample was stirred with a magnetic stirrer and per measurement 
50 ml of the suspension was analyzed. 
2.3.3 Microscopical image analysis 
Microscopical size measurements were performed by the analysis of about 1000 
particles per sample using a Nikon eclipse 50i microscope (Nikon Instruments 
Europe B.V., Kingston, England). The sized particles are classified in size ranges of 
2 µm. For every particle size fraction the average volume of a single particle was 
calculated from the average diameter di of each fraction range assuming an ideal 
spherical shape. By multiplication of the particle count in each fraction with the 
respective single sphere volume the total volume of each fraction was obtained and 
a volume weighted particle size distribution was calculated. 
3 Results and discussion 
3.1 Single object measurements 
Techniques, which are based on reflection measurement, can be assumed to be not 
accurate for particles with strongly convex contours like microspheres. Furthermore 
as this method is strongly depending on the optical properties, the validity of FBRM 
should be critically questioned if it is intended to be used for the analysis of 
reflecting or translucent material. In order to check the quality of the cord length 
analysis and its suitability for particles with convex surfaces, a simple 2-dimensional 
system was chosen to investigate the influence of reflecting and curved surfaces on 
the measured signals. For this purpose thin copper strands with diameters ranging 
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from 80 to 510 µm were attached radially to the sapphire window of the probe. Thus, 
the laser beam should sweep the copper strand only in the transverse direction. As 
the strand has the same diameter at each point not a CLD but a single narrow signal 
peak is obtained. The true diameter of the wires can be easily measured with a 
caliper or micrometer screw. In contrast to particulate objects, which have shorter 
chord length at the flanks, the strands have clearly defined diameters. Nevertheless 
by FBRM values smaller than the true dimensions were obtained. 
The median of the chord length differed between 13 and 28% from the true 
diameters due to the optical surface properties (Tab. 1). As the surface of the 
copper strands is smooth and glossy, the laser light is poorly scattered. Because 
their cross section is not flat, but convex, the intensity of the light which is reflected 
back to the detector from strongly inclined parts of the surface is below the threshold 
of detection.  
Table 1: Median of the square weighted CLD and chord- tangent- angle 
Diameter [µm] 
(micrometer screw) 
Median chord length 
(Sqr Wt) [µm] 
Deviation [%] Angle α [°] 
510 443.8 13.0 60.48 
260 204.7 21.3 41.93 
240 174.1 27.5 46.50 
235 203.0 13.6 59.74 
80 66.2 17.3 55.84 
On the basis of these measurements a critical chord-tangent angle α was calculated 
by computing the arcsine of the quotient of the median chord length (sqr.wt.) and 
the diameter determined by the micrometer screw. α ranged from 44 to 60°, beyond 
which the laser beam is no longer reflected towards the probe head (Fig. 1). The 
copper strands are an appropriate simplified model to study the FBRM signals 
obtained from particles with mainly specular or quasi-specular reflection 
characteristics and convex surfaces. They help to understand the sole influence of 
reflection phenomena on the FBRM signal, unbiased by chord length effects.  
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Figure 1: Cross sectional view of a copper strand: Calculation of the chord tangent 
angle 
3.2 Measurements of monodisperse particle collectives  
As a second model, which considers also the fact that from particulate objects chord 
length distributions rather than uniform values are obtained, monodisperse, 
spherical polystyrene particles of known size were investigated. The shape of a size 
distribution is always determined by the weighting method which is employed. 
Number weighted (called “unweighted” by the Lasentec® software) and square 
weighted CLDs are chosen below according to the issue being addressed. It is often 
stated that the square weighted median of the chord length distribution meets best 
the volume weighted median of the diameter distribution obtained by other particle 
sizing techniques [26, 27]. Also the manufacturer of the Lasentec® device prefers 
the square weighted median for many applications to be used by default. In order to 
check this information, the CLD of monodisperse black polystyrene microspheres 
( = 103.9 µm) was measured by FBRM and compared with the PSD obtained by 
SPOS. First monodisperse samples of black polystyrene microspheres with a 
diameter of 103.9 µm (microscopically sized) were suspended in water 
(concentration < 1%) and measured in a stirred glass beaker. These results were 
compared to values obtained by SPOS measurements. The square weighted 
median of the chord length distribution met best the volume weighted median of the 
diameter distribution obtained by other particle sizing techniques (Fig. 2). This is in 
agreement with Heath et al. and consequently in the further course of the work the 
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square weighted CLD or its median is mainly used for comparison with volume 
weighted PSDs derived from other methods [27]. 
 
Figure 2: Effect of various weightings on the median of the chord length distribution of 
monodisperse black polystyrene microspheres (Ø = 103.9 µm, microscopically sized): 
unweighted median (dashed line): 11.39 µm, square weighted median (dotted line): 
105.32 µm and cube weighted median (solid line): 108.40 µm. 
An explanation for this relationship can be found considering the unweighted ([1,0]) 
and the square weighted ([3,2]) mean chord lengths xmean and x
2
mean. 
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K is the number of intervals, xk is the center of the k
th interval and f(k) is the 
probability of measuring a chord included in the kth interval, The terms in the 
numerators and denominators are the moments of the CLD. As shown by Wynn, 
E.J.W., the ith moment of the CLD (µi) is proportional to the ( i + 1)
th moment of the 
PSD (mi+1) [28]. 
1 iii mUTS  
where U is the speed with which the revolving laser beam progresses, T is the 
scanning depth, and Si is a constant dependent on the particle shape. Thus, square 
weighting of the (unweighted) [1,0] average of the CLD leads to the [3,2] CLD 
average which, according to the above mentioned equation, is proportional to the 
[4,3] average of the PSD. Because this volume weighted mean diameter (d[4,3]) is 
also obtained by laser diffraction, square weighting of the CLD provides a good 
approximation to those volume-based PSDs. 
Surprisingly, in the unweighted distribution shown in Fig. 2 a first peak occurs at a 
small size of only about 10 µm. This signal can be explained by chord splitting which 
means that low-amplitude signals are superimposed by the baseline noise thus 
triggering the analyzer to detect multiple small peaks instead of one large signal 
[25]. Such an artificial chord splitting peak can also be found in case of transparent 
monodisperse polystyrene microspheres (Fig. 3). 
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Figure 3: Optical pathways in case of objects with subsurface scattering (polystyrene 
microspheres), mixed specular and lambertian (copper strands, emulsion droplets), and 
lambertian (e.g. PLGA microspheres) scattering properties  
The CLD of the transparent particles shows also another signal without any obvious 
reference to the particle diameter. This peak at 54 µm can be attributed to specular 
reflection phenomena. As the particles do not have a flat but a convex shape, their 
margins are disinclined to the incident laser beam. In case of a smooth particle 
surface a large proportion of the light is specularly reflected. At a certain surface 
inclination the reflected ray, which makes the same angle as the incident ray with 
respect to the surface normal, does no longer pass the probe’s aperture. A signal is 
detected as long as the light cone hits the particle surface in a position which allows 
at least partial reflection back to the detector. This depends on the beam’s 
divergence angle, the aperture diameter, the distance between aperture and particle 
surface, the particle size, and its distance to the focus point. It can be shown that 
these conditions are fulfilled within a 54 µm-section of the focus path in case of 
98.7 µm microspheres [29]. 
The main peak at 153 µm indicates a chord length which is much larger than the 
diameter of the spheres. Such large chord lengths can only be caused by divergent 
rays of the light cone which hit a particle even before the optical axis reaches the 
particle’s outline. However, during this time frame of oblique illumination no 
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substantial reflection towards the detector can be expected if the surfaces have only 
specular reflecting or Lambertian scattering properties because in these cases 
angular incident beams are reflected in the opposite direction of the detector (at 
least if the particles are not in far distance to the probe window). Only in case of 
internal reflection or subsurface scattering, which occurs if the particles are 
transparent or translucent, a substantial part of the light flux is reflected or scattered 
towards the detector for a longer period than the focus point needs to cross the 
particles projection plane. 
 
Figure 4: Unweighted and square weighted chord length distribution of monodisperse transparent 
polystyrene particles (Ø 98.7 ±1 µm according to manufacturer’s data) 
If the laser beam hits a translucent particle multiple reflections within the particle 
occur and the whole sphere lights up (Fig. 4). This effect lasts from the first contact 
of the light cone with the edge of the particle until the light spot has moved 
completely off the particle. Thus the duration of the signal is longer than the time 
span which the focus point itself would need to pass from the one edge to the other 
and chord lengths larger than the particle diameter are obtained (Fig. 5). Such 
reflection phenomena can explain the third maximum at 153 µm of the unweighted 
CLD curve in Figure 3. 
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Figure 5: Illumination time for subsurface scattering and resulting apparent chord length 
The square weighting of the chord length distribution masks the trimodal distribution 
pattern resulting in only one broad peak with a median (square weighted) of 
141.1 µm and a square weighted mean of 137.2 µm. By contrast the volume 
weighted diameter measured by SPOS shows a very narrow distribution with a 
much smaller mean value of only 98.3 µm. It correlates well with the microscopically 
obtained mean particle size provided by the manufacturer (98.7 µm) and with 
measurements from own photomicrographs (98.9 µm) (Fig. 6a). As the data show, 
there is a considerable deviation between the particle diameter and the chord length 
values measured by FBRM with the latter being about 40% larger than the true 
particle size.  
In order to prove the assumption that this mismatch is caused by internal reflections, 
as discussed above, the measurements were compared with non-transparent, black 
microspheres. The volume weighted median diameter of the black microspheres 
(Fig. 6b) was measured as 103.9 µm with SPOS and exactly the same value was 
also found by microscopy. In this case, however, the square weighted median 
measured with FBRM was found to be 105.0 µm (mean = 98.8 µm), which meets 
the mean particle diameter much better than observed with transparent particles 
(Fig. 2). Due to the high absorbance of the black particles, the backscattered signal 
is only very weak, which results in a high degree of chord splitting recognizable by a 
huge peak at 10 µm in the unweighted distribution. However, the chord splitting 
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peak becomes nearly insignificant if square weighted data are plotted. This effect is 
also reflected by the median of the CLD which rises from 11.39 µm to 105.32 µm 
(unweighted mean: 36.4, square weighted mean: 98.8 µm) when applying the 
square weighted instead of the unweighted distribution.  
Summarizing the aforementioned results, the square weighted mean or median of a 
chord length distribution is a much better estimate for the mean or median particle 
diameter than the unweighted statistics. However, it was also shown that FBRM 
data, regardless by which type of weighting they are obtained, might not represent 
the true size if transparent or translucent particles are measured. 
 
Figure 6: Photomicrographs of transparent (Ø = 98.7 ± 1µm) (a) and black (Ø = 103.9 µm) (b) 
monodisperse polystyrene microparticles 
In contrast to copper strands which are singular objects positioned in a fixed 
distance (i.e. directly at the probe window) particle suspensions contain a large 
number of reflecting objects located at varying distances which are hit randomly by 
the laser beam. Both factors, the particle concentration and their distance from the 
focus point, affect the detector signal. Depending on their distance to the probe a 
more or less broadened light spot is projected onto the particles by the divergent 
beam. As the focus position is displaceable, the cross sectional size of the beam in 
front of the probe window can be varied, which, in turn, changes the reflection 
signal. These complex interactions make it very difficult to pre-estimate the effect of 
these parameters. For this purpose a series of tests was performed to study the 
influence of these factors. 
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3.2.1 Influence of the position of the focal point 
There are different variables which can affect the optimum focus position like the 
particle size range, the solid concentration of the suspension or the optical 
properties like the refractive index of the dispersant. For very fine particles best 
results are usually obtained if the focus is positioned inside the probe window, for 
larger particles the optimum is found by moving the focus position into the 
suspension [17]. A generally recommended default setting given by the 
manufacturer of the Lasentec® instrument is -20 µm, which means, that the focus of 
the laser beam lies slightly inside the sapphire window. The more the focal point is 
moved inside the probe window, the more the laser beam is broadened and 
weakened in front of the window [30]. Thus the intensity of the laser beam hitting the 
particle surface decreases and in turn the backscattered light flux is reduced. This 
causes a change in the measured particle size because reflection from the tilted 
peripheral areas of the spheres falls below the detection threshold. 
To determine whether a more accurate particle size can be obtained with an 
optimized focal position, transparent polystyrene particles were measured with 
varying positions of the focus ranging from -80 to +200 µm. A focus position 
between -40 and 100 µm showed no significant influence on the unweighted and 
only a slight influence on the square weighted median chord length (Fig. 7). Only a 
position of the focal point more than 40 µm inside the probe window produced a 
sudden and significant drop of the measured particle size. However, neither the 
unweighted nor the square weighted median of the CLD reached the true particle 
diameter even at the -80 µm focus position. The focus position seems to be a 
parameter which has only limited influence on the measured particle size. For this 
reason the default setting of -20 µm was maintained for all further measurements.  
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Figure 7: Influence of the focus position on the unweighted (-▲-) and square weighted (-■-) 
median of the CLD of transparent monodisperse polystyrene microparticles ( = 98.7 ± 
1µm) 
3.2.2 Influence of the particle concentration  
FBRM is a particle sizing method, which is well suited for analysis in suspensions 
with a high solid concentration. In typical solvent extraction evaporation processes 
for the preparation of PLGA microparticles the concentration is about 0.2% and thus 
it is rather low with respect to the range covered by this measuring method. To 
ascertain whether the method can be used for such applications, low concentrated 
suspensions with 0.2 to 3% (m/v) solids were investigated using slightly translucent 
PLGA microspheres. Despite a volume weighted median of the PSD of 103.2 µm, 
determined with SPOS, the square weighted median of the CLD (FBRM 
measurement) ranged between 79.5 and 82.5 µm depending on the particle 
concentration. The maximum value was found at a solid concentration of 1% 
(Fig. 8). Above this concentration it decreases marginally, which is in accordance 
with the findings of Yu et al., who reported, that the square weighted median of the 
CLD decreases with rising solid concentration of PVC particles [26]. By analyzing 
single ceramic beads Ruf et al. constituted that the laser penetration depth is 
reduced with an increase of the solid concentration and is thus limiting the diameter 
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of the light spot by which the furthermost particles are scanned [25]. At a high solid 
concentration only those particles are detected, which are passing the laser beam in 
short distance to the probe window, and thus very close to the focal point.  
If the particle concentration is low also particles, which are not directly at the probe 
window are detected. The deeper the laser beam penetrates into the suspension, 
the more it is widened and the measuring signal is prolonged. For this reason the 
median of the CLD increases slightly when the solid concentration decreases. In 
case of very low solid concentrations weak reflections from distant particles cause 
noisy fluctuations of the detected signal, resulting in chord splitting as described 
above. This leads to a sharp decline of the square weighted mean at particle 
concentrations below 1%. Yu et al. could find this behavior only for the unweighted 
mean but with no effect on the square weighted mean [26]. 
 
 
Figure 8: Correlation between square weighted CLD and solid concentration (% m/v) in 
suspensions of PLGA microparticles  
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Although the FBRM is applicable for a wide concentration range, its main field of 
application is the measurement of dispersions with high solid concentrations. As the 
experiments show, a variation of the concentration from 0.2 to 3.0% does not 
change the square weighted median chord length by more than 3 µm which is 
acceptable for the intended application of the method. Considering this low 
sensitivity to the solids concentration within the range of interest, the method was 
shown to be also suitable for processes with highly diluted suspensions, e.g. for 
monitoring of microparticle preparation by emulsion/solvent removal techniques.  
3.2.3 CLDs of heterodisperse particle collectives and emulsion droplets 
As mentioned above, microparticles consisting of PLGA are usually slightly 
translucent depending on type, amount and dispersity of incorporated drug 
substances. Before using FBRM for in-process monitoring in PLGA-microparticle 
preparation, it has to be clarified whether the kind of reflectiveness allows for 
accurate measurements or whether a high degree of internal scattering distorts the 
results. 
A series of batches of plain and drug loaded PLGA microspheres was produced 
under different process conditions by varying the stirrer speed and the rate of the 
head space ventilation. As can be seen by microscopy, all tested PLGA particles 
have a rougher surface and are much less translucent than PS particles, which 
leads to the expectation that superficial scattering might be more pronounced than 
internal scattering or reflection (Fig. 9). 
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Figure 9: PLGA placebo microspheres (batch no. 4 (Tab.2)) 
The particle size of the samples was analyzed by FBRM and SPOS. For all types of 
particles the two methods produced diverging results, with the square weighted 
median of the CLD (measured by FBRM) being consistently lower than the volume 
weighted median of the PSD (obtained by SPOS) (Tab. 2, batches 1-5). 
Table 2: Process parameters of PLGA microspheres and CLD, resp. PSD measured by 
FBRM and SPOS 
Batch 
No. 
API Air flow 
[l/min] 
Stirring speed 
[rpm] 
FBRM - 
Median Sqr Wt [µm] 
Accusizer - 
Median Vol Wt [µm 
1 ― 10 260 39.28 61.43 
2 + 10 260 71.8 83.7 
3 ― 5 220 48.47 58.11 
4 ― 5 120 36.14 55.04 
5 + 5 120 38.25 50.37 
6 ― 1 220 39.49 56.31 
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Due to the particles’ poor transparency, this deviation is mainly caused by non-
Lambertian reflection phenomena, most probably by those of a specular type, which 
were shown above to decrease the measured chord lengths.  
Figure 10 shows, as an example, the cumulative volume weighted PSD and the 
square weighted CLD of particle batch 2. As indicated by about the same slope of 
both curves, square weighting is able to transform a CLD into an equally shaped 
distribution as the PSD. The missing congruence in form of a parallel offset is due to 
the difference of the medians which is caused by the fact that the particles show 
also other types of reflection than solely diffuse (Lambertian) surface scattering.  
 
Figure 10: Cumulative size distributions of PLGA microspheres (batch 2) measured with FBRM and 
SPOS  
In microparticle manufacturing by a solvent extraction/evaporation process, which is 
based on the preparation and further processing of a primary emulsion, monitoring 
of the initial droplet size and its change in the course of the process can be a 
valuable tool for development and process control. The determination of the primary 
emulsion’s initial droplet size is a demanding problem as the droplets are 
transparent and thus FBRM might not provide accurate values. On the other hand 
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the emulsion is too concentrated for undiluted measurement with SPOS. Dilution 
however causes solvent extraction and in turn changes of the droplet size. 
To clarify these problems the emulsion was measured on the one hand with the 
FBRM probe mounted in a flow through cell at the outlet of the mixer and on the 
other hand with microscopic image analysis. As expected, due to their transparency 
the droplets caused only low backscatter to the detector. The square weighted 
median of the chord length measured with FBRM was 41.8 µm which is only half of 
the mean droplet size obtained by image analysis (Fig. 11). This demonstrates that 
FBRM is strongly dependent on the optical properties of the measured specimens 
and is not an appropriate method to determine the size of transparent emulsion 
droplets. This is in agreement with Greaves et al. and was also found by Sparks and 
Dobbs, who concluded that only droplets which are opaque and highly reflective 
(with microstructure on the surface) give reproducible and accurate results [31, 17]. 
 
Figure 11: Comparison of the droplet size distribution measured with FBRM (―) (median (square 
wt): 41.8 µm) and with image analysis by microscopy (---) (median (vol wt): 94.7 µm) 
The unweighted CLD of the emulsion (data not shown) shows again a very high 
number of small chord lengths, as in the case of the transparent polystyrene 
microparticles. This indicates again the phenomenon of chord splitting which 
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appears if reflection is weak. Thus, the at-line measurement of the primary emulsion 
and the finished particles demonstrates that FBRM does not provide reliable values 
for emulsion droplets. The finished microspheres, however, can be measured in 
many cases with only small and acceptable deviations.  
3.3 Online-monitoring of a microparticle preparation process by 
FBRM 
While FBRM is only of limited use for measuring absolute droplet or particle size 
distributions, it can nevertheless be an appropriate tool for process monitoring. This 
was studied with different batches of microspheres which were prepared under 
conditions with modified solvent extraction from the emulsion droplets, resulting in 
“rapid” or ”slow” hardening of the microspheres. The rate of solvent evaporation has 
a strong influence on the encapsulation efficiency and on the morphology of the 
resulting microspheres, which is an important factor controlling the drug release [32, 
33].  
Two batches prepared at 35 °C with different stirring speed and air flow were 
compared to each other. Fast solvent extraction was obtained at a high stirring 
speed of 260 rpm and an intensive air flush of 10 l/min through the head of the 
reactor (batch no. 1). The process parameters for slow extraction were 120 rpm and 
5 l/min (batch no. 4) (Tab. 2). As described above, the FBRM is strongly dependent 
on the surface properties and the transparency of the measured samples. For this 
reason different values are obtained from emulsion droplets and equally sized 
solidified particles. Thus the transition of liquid emulsion droplets into solid 
microparticles should be accompanied by a significant change of the FBRM signal.  
As Figure 12a shows, in case of fast solvent removal the first measurable (artificial) 
value for the square weighted median is about 28 µm. Within a minute it increases 
to 40.8 µm (sqr. wt median). By contrast, slow solvent extraction produces particles 
with initial FBRM signals of more than 160 µm. However, within the first 4-6 minutes 
of the process the signal drops down to a value of 45 µm, which corresponds to the 
apparent size of the rapidly extracted particles. 
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Figure 12a: Droplet, resp. particle size during processing of placebo microparticles with fast (10 
l/min, 260 rpm; batch no. 1) and slow (5 l/min, 120 rpm; batch no. 4) solvent extraction 
There are also other ways to slow down the solvent extraction rate und thus to affect 
the product properties, e.g. to apply a low process temperature of only 10 °C. Under 
these conditions of fast stirring and fast air flush (260 rpm, 20 L/min) but low 
extraction temperature (10 °C) a significantly higher initial particle size (about 
100 µm) than in case of 35 °C and otherwise equal parameters was measured. 
Again it dropped down to about 45 µm after 1-2 minutes. Feeding the emulsion 
droplets into an aqueous phase already containing methylene chloride was tested 
as an option to decelerate the extraction process. However, the addition of 0.6% of 
methylene chloride to the aqueous phase did not render a markedly delayed particle 
formation (Fig. 12b). 
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Figure 12b: Droplet, resp. particle size of placebo microparticles during processing with solvent 
extraction at 10 °C (air flow: 20 L/min, stirring speed: 260 rpm) with methylene chloride 
addition to aqueous phase (---) and without solvent in the extraction phase (-+-)  
It has to be pointed out that the measured size values must not be considered as 
true particle sizes rather than as FBRM signals which are strongly determined by 
the optical properties of the particles and thus need a thorough interpretation 
regarding the information derivable from these data.  
The first process, which starts even in the mixer and continues after the emulsion is 
fed into the extraction tank, is a very fast redistribution of methylene chloride from 
the droplets into the continuous phase and into the extraction medium. As long as 
the polymer solution in the droplets is rather diluted solvent removal does not cause 
any, not even any locally limited phase transition. The droplets remain liquid but lose 
solvent within seconds and shrink abruptly in size. This step is too fast for 
monitoring it by FBRM. After the polymer concentration has reached a certain limit 
the further course of the process is determined by the rate of solvent removal.  
In case of fast solvent extraction, the polymer solidifies rapidly on the droplet 
surface [34], which, as a result, becomes to a certain degree diffusely scattering. 
This change from solely specular reflecting to partly Lambertian scattering 
properties is most probably the reason for the apparent increase of the median 
chord length from about 28 to 40 µm, which can be seen in Figure 12a. During 
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further processing, water molecules penetrate into the initially solvated polymer 
matrix and replace the molecules of the organic solvent. The subsequently 
hydrated, as well as the initially solvated microparticles show a smooth surface with 
partly diffuse but dominating specular characteristics like in case of the copper 
strands described above. Thus the value obtained by FBRM is distinctly smaller 
than the true particle size which was found to be characteristic for specular objects. 
The square weighted median of about 40 µm remains constant all over the 
extraction period which indicates, that the optical properties do not change for the 
entire duration of the process.  
In case of slow extraction, during the first 2 to 4 minutes the square weighted 
median is considerably higher than the value which is measured for the primary 
emulsion. Subsequently, it drops down to a value between 40 and 50 µm which 
remains nearly constant until the end of the extraction process. This phenomenon 
could be observed for all batches with decelerated solvent removal irrespectively of 
the method by which the extraction rate was decreased. As shown by the 
preliminary experiments subsurface scattering was identified as the main reason for 
a significant overestimation of the particle size. Most likely it causes also the 
apparent droplet expansion immediately after feeding the emulsion into the 
extraction medium. In case of slow solvent extraction no instantaneous formation of 
a skin layer on the particle surface is to be expected. Instead segregation processes 
inside the droplets or embryonic particles are recorded. Due to phase separation the 
optical properties of the previously transparent emulsion droplets change to opaque. 
Under the microscope the formation of a granular structure inside the particles can 
be observed in this phase. After this transitional stage, solidification progresses with 
a further opacification of the internal particle structure and the formation of a smooth 
and largely specular surface which both impede the penetration of the laser beam 
into subsurface regions. The specular reflection behavior causes an 
underestimation of the particle size as discussed before. Thus the decrease of the 
FBRM signal has to be assumed not to reflect a size change but rather marks the 
point where particle solidification occurs. 
In all cases the conversion of liquid droplets into solid particles was exceptionally 
fast. At the latest about 4-6 minutes after feeding the emulsion into the reactor the 
square weighted median had reached its final value. This period of the process has 
therefore the greatest impact on the resulting particle morphology and should be the 
main target for measures to control the particle properties.  
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In the preparation of drug loaded PLGA particles another additional phenomenon 
could be observed by FBRM. In some cases about 40 minutes after starting the 
process a high signal peak occurred at a chord length of 185 µm (Fig. 13a).  
 
Figure 13a: CLD pattern during processing. CLD at the beginning of the process (―) after delivering 
the emulsion into the reactor and after 40 minutes of process duration (--) of batch no. 5 
Subsequently this main peak shifted from 185 µm to 90 µm and then a third peak 
appeared at 35 µm. After another 50 min the peaks disappeared completely 
(Fig. 13b). After occurrence of the first signal peak a sample was taken and 
examined microscopically, revealing thin drug crystal needles with a length up to 
approximately 200 µm. 
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Figure 13b:  Occurrence of crystal needles and shift of the signal peaks during processing 
(batch 5) 
By encapsulating a high amount of the poorly water soluble active ingredient into 
polymer particles, the process can get unstable under unfavorable process 
conditions. 
If hardening of the microspheres occurs too slowly (batch no. 5, Tab. 2), the drug 
substance is not tightly enclosed inside the polymer matrix and can diffuse out of the 
nascent particles and precipitate in the aqueous phase (Fig. 14). These needle 
shaped crystals are detected by FBRM and sharp peaks occur representing their 
longitudinal dimension. In the course of stirring the fragile crystal needles break to 
pieces and the signal shifts to smaller values. It seems that each fracture results in 
needles with about half the size of the initial crystals (185 µm  90 µm  35 µm). 
At a certain time point, the needles are so small, that their signals cannot be 
distinguished from those of the microspheres.  
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Figure 14: Crystal needles and microparticles in aqueous phase during processing (batch 5) 
4 Conclusions 
In this work the use of focused beam reflectance measurement for the determination 
of chord length distributions of spherical microparticles and emulsion droplets and 
its applicability for monitoring of microparticle preparation processes has been 
studied.  
FBRM data are highly dependent on the material properties of the analysed 
samples and were influenced by measuring parameters like the solid concentration 
in the suspension or the focal point position. Materials with reflective properties due 
to smooth surfaces are not suitable to be accurately analysed by FBRM. They tend 
to provide signals much smaller than their true particle size. By contrast, translucent 
emulsion droplets usually originate signals mimicking too large particles. However, 
the size of particles with a rough surface and thus good backscattering properties, 
like PLGA microspheres, could be well estimated.  
In spite of these limitations, FBRM is a strong tool to provide new insights into the 
microparticle formation in a solvent removal process. The transformation of the 
emulsion droplets into solidifying particles can be detected by a change in the 
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FBRM signal. In a solvent extraction/evaporation process based on methylene 
chloride, solidification of the emulsion droplets and particle size changes occur 
within the first seconds to minutes after feeding the emulsion into the reactor. These 
changes cannot be monitored by any at-line particle size measurements. As the 
FBRM signal is strongly depending on the surface properties of the measured 
sample, it provides an effective solution to track this process. It is a great advantage 
of the FBRM, that it requires no sampling and separate analysis. With regard to 
controlling such a microparticle preparation process the determination of the rate 
and time point of conversion from liquid droplets to solid particles is of great interest. 
The solidification rate is an important parameter influencing the encapsulation 
efficiency and the initial burst in microparticulate systems. A very slow hardening of 
the emulsion droplets leads to the diffusion of the drug substance out of the droplets 
and precipitation in the external phase. This event could be monitored by FBRM. 
For these reasons FBRM is a useful tool to investigate the effect of different process 
variables, like stirring speed or air flow, on the solidification rate and to assess its 
influence on the resulting particles and thus can help support a subsequent scale up 
process. However, unlike conventional applications of FBRM, monitoring of such 
processes which are accompanied by changes of optical properties requires a 
thorough understanding of the measuring principle and a deep knowledge of signal 
generation and processing by the instrument. Basically, FBRM is not a trivial 
method. In every application the possibility of artefacts due to changes of reflective 
properties should be considered and results should always be critically questioned. 
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CHAPTER 5 
A detailed view of microparticle formation by in-
process monitoring of the glass transition 
temperature ‡ 
 
Abstract 
Biodegradable poly(D,L-lactide-co-glycolide) microspheres were prepared by a well-
controlled emulsion solvent extraction/evaporation process. The objective of this 
study was to investigate how drug release can be modified by changing the 
morphology of the polymer matrix. The matrix structure was controlled by the 
preparation temperature which was varied between 10 and 35 °C, thus changing the 
four weeks release pattern from almost linear kinetics to a sigmoidal profile with a 
distinct lag phase and furthermore decreasing the encapsulation efficiency. By 
monitoring the glass transition temperature during the extraction process it was 
shown that the preparation temperature determines the particle morphology by 
influencing the time span in which the polymer chains were mobile and flexible 
during the extraction process.  
Further factors determining drug release were found to be the molecular weight of 
the polymer and the rate of solvent removal. The latter, however, has also influence 
on the encapsulation efficiency with slow removal causing a higher drug loss. A 
secondary modification of the outer particle structure could be achieved by ethanolic 
post-treatment of the particles, which caused an extension of the lag phase and 
subsequently an accelerated drug release.  
 
‡
 Published in European Journal of Pharmaceutics and Biopharmaceutics 2012, 81 (2), 399-408. 
Vay,K.; Friess,W; Scheler,S., A detailed view of microparticle formation by in-process monitoring of 
the glass transition temperature. 
CHAPTER 5                                                                                                                                                
 92 
1 Introduction 
By now a variety of biodegradable poly(lactide-co-glycolide) microspheres for the 
sustained release of several drug substances are commercially available. As many 
new drugs are peptides, proteins or small molecules with low solubility and 
permeability and thus poor oral bioavailability research on these dosage forms is still 
of growing interest [1]. Biodegradable depot formulations offer numerous benefits. 
For example they can help to reduce side effects and to enhance the therapeutic 
compliance and efficiency. 
There is a variety of different preparation techniques to encapsulate an active 
ingredient into a PLGA matrix including coacervation, spray drying, melting 
techniques, methods using supercritical fluids and emulsion solvent removal 
techniques. The latter is the oldest and most popular technique, especially for active 
ingredients with poor water solubility [2-4]. The influences of numerous process 
parameters on the characteristics and the drug release profile of the resulting 
microspheres have been extensively studied [5-8]. It was shown that drug release 
from these dosage forms depends strongly on the molecular order, the amorphous 
or crystalline state of the active ingredient and how it is embedded in the polymer 
matrix. Furthermore the morphology of the surrounding polymer matrix is crucial for 
the resulting drug release rates.  
Most of these studies concerned drug substances with good aqueous solubility and 
thus the results are not valid for drugs with poor water solubility. Furthermore the 
majority of the experiments were performed on a laboratory batch scale without 
exact determination of the solvent removal rate and temperature of the external 
phase. We examined the structure formation mechanism of PLGA microspheres in a 
well-controlled emulsion solvent extraction/evaporation process on a 5 L batch scale 
by monitoring the glass transition temperature during solvent removal. The 
encapsulated drug was 4-[2-[4-(6-fluorobenzo[d]isoxazol-3-yl)-1-piperidyl]ethyl]-3-
methyl-2,6-diazabicyclo[4.4.0]deca-1,3-dien-5-one, a substance with poor aqueous 
solubility. 
The glass transition temperature (Tg) of the polymer, which marks the change 
between the rigid, glassy and the more flexible, rubbery state, is closely correlated 
to the amount of solvent in the polymer matrix. As the latter decreases in the course 
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of the extraction step, the Tg should rise during the microsphere preparation 
process. It can be assumed that the morphology of the particle structure is only 
formed in the rubbery state, as long as Tg is below the process temperature. As the 
extraction rate is also controlled by the process temperature, it can be expected that 
the mobility of the polymer chains and the duration of the rubbery phase is 
determined by the extraction temperature in a complex way [9]. We investigated the 
change of Tg during processing in relation to the applied extraction temperature and 
its influence on the particle morphology and functional characteristics. 
As the Tg of the forming microparticles is strongly dependent on the solvent content 
in the polymer matrix we assumed that the modification of the solvent removal rate 
should result in a change of the particle properties. These factors are supposed to 
be in close interaction with the molecular weight of the polymer, which was also 
varied in this study. Similarly and as a third factor investigated subsequent 
suspension of the resulting microspheres in a second solvent or solvent-water-
mixture should also change the particle morphology and thus alter the drug release 
profile. 
Firstly, however, for a better understanding of the process data, we examined the 
influence of the solvent concentration on the glass transition temperature of the 
polymer in the presence and absence of the drug substance and correlated the 
experimentally derived Tg values with the theoretical ones predicted by the Gorgon-
Taylor-Equation. 
2 Materials and Methods 
2.1 Materials 
Poly(D,L-lactide-co-glycolide) 75:25 with different molecular weight were purchased 
from Boehringer Ingelheim, (Ingelheim, Germany): Resomer 753S (36510 Da), 
Resomer 755S (57670 Da), and Resomer 756S (107200 Da) (Tab. 1). Methylene 
chloride analytical grade was obtained from Merck (Darmstadt, Germany), and TRIS 
(Tris(hydroxymethyl)aminomethan) from AppliChem (Darmstadt, Germany). 4-[2-[4-
(6-fluorobenzo[d]isoxazol-3-yl)-1-piperidyl]ethyl]-3-methyl-2,6-
diazabicyclo[4.4.0]deca-1,3-dien-5-one was purchased from Jubilant Organosys 
(Mysore, India) and PVA 18-88 from Kuraray Europe GmbH (Frankfurt, Germany). 
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Table 1: Characteristics of the different types of PLGA (75:25) used 
PLGA 75:25 
Weight average 
molecular weight (Mw in 
Da) 
Polydispersity 
(Mw/Mn) 
End 
group 
Inherent viscosity 
[mL/g] 
RG 753 S 36510 1.6 Alkyl 0.39 
RG 755 S 56020 1.6 Alkyl 0.56 
RG 756 S 109200 1.6 Alkyl 0.98 
2.2 Microparticle preparation 
An emulsification solvent extraction/evaporation technique was employed to prepare 
PLGA microparticles. For plain particles (free of drug) 4.8 g PLGA, for all other 
particle batches 3.8 g active agent and 5.1 g PLGA were dissolved in 46.1 g of 
methylene chloride and the solution was emulsified with 500 ml of 0.5% (w/v) 
povidone in 0.1 M Tris buffer (pH 9.0) (aqueous phase). The emulsion was fed into 
a 5 L jacketed glass reactor containing additional 3.5 L of the aqueous phase. By 
stirring for 5 hours the droplets were hardened by solvent extraction and 
evaporation with an air flow of 10 L/min (exactly regulated by a mass flow controller 
(red-y smart meter, Vögtlin instruments AG, Aesch, Switzerland)) and a stirring 
speed of 260 rpm (curved blade paddle-type stirrer). The obtained particles were 
separated by filtration and dried under vacuum in a desiccator. Different particle 
batches were produced by varying the extraction temperature between 10 and 
35 °C. For further modifications the air flow was reduced to 1.5 L/min and the stirring 
speed to 180 and 220 rpm. In another experiment, after collection on a filter, the 
particles were re-suspended in 25% ethanol at 25 or 40 °C for 1 or 2 hours, 
collected and dried as described above. 
2.3  Analytical methods 
2.3.1 Thermal analysis – Differential scanning calorimetry (DSC) 
The glass transition temperature (Tg) was determined by differential scanning 
calorimetry (DSC) using a DSC (823e/500) (Mettler Toledo (Greifensee, 
Switzerland)). For in-process measurements about 50 ml of the suspension were 
sampled (after 10, 30, 60, 120, 180, 240 minutes of processing and at the end of the 
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process) and centrifuged at 4000 rpm for 2 minutes. Approximately 10 mg were 
weighed into 40 µl aluminium pans and hermetically sealed. As a reference an 
empty aluminium pan was used. Samples were cooled down to -40 °C and then 
heated up to 80 °C at 10 °C/minute to eliminate any sample history, cooled to -10 °C 
and then heated again up to 200 °C at 10 °C/minute. For Tg determination the data 
were analyzed using the STAR software (Mettler Toledo, Switzerland) and the 
midpoint of the corresponding glass transition was evaluated. The Tg was 
determined in duplicate at every time point of sampling. 
2.3.2 Particle size – Single Particle Optical Sizing (SPOS) 
The particle size distribution was determined by single particle optical sizing (SPOS) 
with an Accusizer 780 particle sizing system (Anasysta, Santa Barbara, CA). 
Approximately 20 mg of microspheres were suspended in an aqueous solution of 
polysorbate 80 and deagglomerated by sonication. Per measurement a minimum of 
10000 particles were sized. 
2.3.3 Particle morphology characterization - Scanning electron 
microscopy (SEM) 
The morphological structure of the particles was examined by scanning electron 
microscopy (JEOL JSM – 5310LV; JEOL Ltd., Tokyo, Japan). To study the internal 
structure, the particles were frozen in liquid nitrogen and cut with a razor blade. The 
specimens were sputtered with gold. 
2.3.4 Drug distribution – Chemical Imaging  
The drug distribution inside the microspheres was analyzed by IR-Imaging of cross-
sections of the microspheres. To produce even cross sections, the microspheres 
were as first step embedded in an epoxy resin, afterwards cooled in liquid nitrogen 
and cut with a high precision milling cutter (Leica EM Rapid, Leica Microsystems 
GmbH, Wetzlar, Germany).  
From this cross section, an IR image of 150x150 µm area with a pixel size of 
1.56 µm was subsequently obtained with a Perkin Elmer Spectrum&Spotlight 400 
IR-NIR (PerkinElmer LAS, Rodgau-Jügesheim, Germany) imaging system. The IR 
spectra were obtained between 4000 – 750 cm-1 with a spectral resolution of 4 cm-
1 and 2 spectra averaged per pixel. To display the distribution of PLGA and the drug 
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substance within the obtained image, the adsorption intensity images at 1643 cm-1 
(characteristic for the drug substance) and 1747 cm-1 (characteristic for PLGA) 
were selected. 
2.3.5 Drug loading and in-vitro dissolution studies –RP-HPLC 
The drug load of the microspheres was determined by dissolving 20 mg 
microspheres in 25 ml acetonitrile using sonication and filling up to 200 ml with 
0.1 M HCl. The drug concentration was determined by HPLC with a DAD detector at 
235 nm and evaluated with the Chromeleon 6.7 software (Dionex, USA). A RP 18 
column (20 x 2.1 mm) column was used with a flow rate of 1 ml/min and an injected 
volume of 50 µl. The mobile phase consisted of a 75:25 (v/v) mixture of 
0.25 M phosphate buffer (pH 8.5) and acetonitrile. A membrane filtered (0.45 µm 
hydrophilic cellulose filter) clear test solution was analyzed.  
For the in-vitro release studies the microspheres (17 mg) were placed in 100 ml of a 
10 mmol phosphate buffer solution (pH 7.4) in a screw cap bottle and incubated in 
electrically heated aluminum blocks with drill holes on an orbital shaker (rotating 
speed 200 ± 10 rpm) at 37 °C. At predefined time points 0.2 ml samples were taken 
and analyzed by HPLC as described above.  
2.3.6 Molecular weight of PLGA – SE-HPLC 
30 mg microparticles were dissolved in 5 ml tetrahydrofuran. The molecular weight 
was determined by gel permeation chromatography with refractive index detection. 
Three columns (30 x 8 mm) filled with a stationary phase of styrene-divinylbenzene 
copolymers with different pore sizes (0.1, 10, 100 µm were connected in series for 
the size separation. THF was used as mobile phase, stabilized with 0.025% of 
butylhydroxytoluene.  
3 Results and discussion 
3.1  Effects on the glass transition temperature of the polymer 
In microparticle formation the structure of the polymer matrix is a result of the 
arrangement of the polymer chains and is thus strongly determined by the mobility 
of the chains before they become fixed in their final positions. This stage is achieved 
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when the Tg falls below the process temperature and the polymer changes from a 
rubbery to a glassy state. During the preparation of PLGA microspheres a variety of 
formulation and process parameters affect the Tg of the polymer and thus influence 
the microparticle formation [10]. One of them is the type of organic solvent utilized 
and its concentration profile during extraction. We investigated this effect by 
monitoring both, the concentration of methylene chloride and the Tg of the hardening 
microspheres.  
A significant decrease of the methylene chloride concentration in the microspheres 
took place in the first hour of processing (Fig. 1). During this period most of the 
solvent is extracted. The further removal of the remaining solvent from the particles 
occurs slowly. Depending on the extraction temperature a fraction between 1 and 
3.5% of methylene chloride remains in the particles. The most effective removal of 
the solvent is achieved with a process temperature of 35 °C. The lower the process 
temperature the higher is the amount of residual solvent in the microspheres. 
 
Figure 1:  Concentration of methylene chloride in PLGA microspheres during solvent extraction 
(referring to solvated and hydrated particles) at 10 °C (-x-), 20 °C (---), 27.5 °C (--), 
30 °C (--) and 35 °C (--) 
In order to analyze whether the plasticizing effect of the solvent is the only factor 
determining the Tg and, otherwise, to detect additional parameters of influence, the 
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solvent concentrations were plotted against the measured Tg and regressed using 
the Gordon-Taylor-equation (Eq. (1)).  
 
pp
gssgpp
gm
wkw
TwkTw
T


          (1)  
The Gordon Taylor equation, which has been developed to calculate the glass 
transition temperature of polymer blends, has proved to be also applicable to predict 
of the Tg of polymers which are plasticized by solvents, i.e. to predict the glass 
transition temperature of polymer/solvent mixtures (Tgm). In equation 1 Tgp and Tgs 
are the glass transition temperatures of the polymer and the solvent while wp and ws 
are the weight fractions of the two components. k is a constant. In a first step the 
relationship between solvent concentration and Tgm was investigated with placebo 
PLGA microspheres (Fig. 2). As expected, the Tgm decreases with increasing 
amount of residual solvent. The Tgm values range between 22.5 and 32.5 °C for 
amounts from 4.2% to 0.9% of methylene chloride (the amount of methylene 
chloride was calculated referring to the undried sample weight). Regressing the 
glass transition temperature on the amount of residual methylene chloride, a value 
of 36.0 °C was calculated for Tgp (Tg of the polymer with 0% methylene chloride in a 
fully hydrated state), which is consistent with  the literature [11]. For Tgs a value of -
173.0 °C was obtained (corresponding to 100% methylene chloride) which also 
meets the literature values for the Tg of methylene chloride ranging between -170 
and -174 °C [12]. Identical results are also obtained by using the Kelley-Bueche 
equation (Eq. (2)) instead of the Gordon-Taylor equation. 
 
 pspp
gspsgppp
gm
V1V
TV1TV
T


         (2) 
where Vp is the volume fraction of the polymer, p and s are the volumetric 
expansion coefficients of the polymer and the solvent, respectively. The other 
symbols have the same meaning as before. In this case also the expansion 
coefficients are close to values given in literature: p = 5.310-4 °C-1 (Lit.: thermal 
expansion coefficient for polylactic acid (PLA) = 7.410-4 °C-1 [13], p for PLGA is 
assumed to be close to p for PLA) and s = 8.610-4 °C-1 (Lit.: 1.410-3 °C-1) [14]. 
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Figure 2:  Correlation between concentration of methylene chloride and Tg for plain microparticles: 
measured values () and regression line calculated by the Gordon-Taylor-equation  
The samples were taken from the aqueous suspension and the polymer matrix was 
therefore fully hydrated, reducing the Tg of the polymer from 54 °C in the dry state to 
36 °C. Methylene chloride has a much stronger impact on the glass transition 
temperature than the water molecules, reflected by a decreasing Tg with rising 
methylene chloride concentrations. Overall, for the placebo microparticles the 
experimentally determined glass transition temperatures at different methylene 
chloride concentrations are in good agreement with the calculated values and hence 
other factors co-influencing the Tg can be excluded. 
At the beginning of the process, the polymer is fully solvated by methylene chloride. 
During processing the methylene chloride is extracted from the hardening particles 
and in return water diffuses into the particles. Both, methylene chloride and water 
have a plasticizing effect on the Tg of the PLGA. If poly(lactide-co-glycolide) 
copolymers undergo the transition between their glassy and rubbery state, the 
molecular relaxation time changes. The polymer chains get more mobile and 
molecular deformation occurs [15-17]. The small solvent molecules embed 
themselves between the molecules of the amorphous solid and increase the 
spacing and free volume of the sample, resulting in an increased degree of 
molecular mobility. An increase of the Tg, called antiplasticization, can for example 
occur by the addition of a drug substance to the polymer matrix [18]. 
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In case of drug loaded PLGA microspheres a similar correlation was found. 
However, for these particles experimentally determined Tg values deviated stronger 
from the theoretical Tg values (Fig. 3). Starting with about the same T1 value for the 
fully hydrated microparticles as in case of placebo microparticles, the Tg decrease is 
steeper with rising methylene chloride concentration. As can be seen in SEM, the 
active ingredient is deposited in the polymer matrix mainly in crystalline form and 
only a very small portion is molecularly dispersed [19]. The crystalline fraction is not 
active with respect to the Tg depression. When the methylene chloride in the 
particles increases, more drug becomes dissolved, which obviously causes a 
substantial additional plasticizing effect. 
 
Figure 3:  Correlation between concentration of methylene chloride and Tg depression for drug 
loaded particles: measured values () and regression line calculated by the Gordon-
Taylor-equation  
3.2 Effect of the process temperature on the particle properties 
3.2.1 Influence on the particle morphology 
Previous experiments showed that particles with different drug release and 
morphology, specifically pore size distribution, can be obtained when the extraction 
temperature was varied between 10 and 35 °C [16]. In order to understand the role 
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of the process temperature on the structure formation the extraction process was 
monitored. In a series of microparticle preparation processes at 10, 20, 27.5, 30, 
32.5, and 35 °C both the glass transition temperature of the polymer and the amount 
of residual methylene chloride within the particles were measured in intervals 
between 10 and 60 minutes. All other process variables like stirring speed or air 
flush through the reactor were kept constant. Fig. 4 shows the Tg changes during 
solvent extraction. In all experiments the first sample, which was withdrawn 10 min 
after the emulsion was fed into the reactor, had a Tg between 8 and 17 °C. In the 
further course of the preparation process the samples showed an increase of the Tg. 
In all cases the Tg did not increase at a constant rate. After an initial fast phase, the 
increase slowed down and in some cases came to a hold. The substantial change in 
Tg during the first 90 minutes of processing corresponds to the loss of methylene 
chloride from the microspheres (Fig. 1). Depending on the applied process 
temperature the final Tg value ranged from 22 °C for 10°C (Fig. 4a) to 34 °C (Fig. 4f) 
for 35 °C process temperatures. Except for the experiment at 10 °C the Tg tended to 
approach the process temperature.  
At the beginning of the process the Tg of the microspheres is below 17 °C due to the 
high concentration of methylene chloride in the polymer matrix and rises with 
decreasing solvent concentration. Usually mass transfer processes start with a high 
rate when the concentration gradient is high and decelerate when the reservoir 
depletes. This should be reflected in the Tg vs. time profiles. During the first 60 min 
(30 minutes in case of the 27.5 °C experiment) of the studied solvent evaporation 
process a slight acceleration of the Tg increase could be observed. We assume that 
the solvent transfer from the particles into the extraction medium may be 
superimposed by another mass transfer within the particles which is caused by 
phase separation. 
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Figure 4:  Change of the Tg (--) depending on the applied preparation temperature (―) of 10 °C 
(a), 20 °C (b), 27.5 °C (c), 30 °C (d), 32.5 °C (e) and 35 °C (f) 
Phase separation occurs when a solved polymer precipitates and a polymer rich 
phase separates from a solvent-rich phase. This process accelerates the 
desolvation of the polymer. Because of its poor solubility in PLGA the drug will 
partition mainly into the solvent phase. However, if the volume of the solvent phase 
shrinks due to a proceeding solvent extraction, the drug is forced to redistribute into 
the polymer matrix where it intensifies the plasticizing effect of the remaining 
methylene chloride. This process could explain the temporary drop of the Tg at 
about 90 minutes which occurs only in drug loaded but not in plain microparticles 
(data not shown). 
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Overall, a higher variance at the first sampling time point may be due to the fact that 
the Tg is more difficult to analyze with high amounts of residual solvents, because 
the change of the DSC signal is small and prolonged. With decreasing amount of 
methylene chloride the transition becomes more distinct.  
The process temperature also influences the amount of residual solvent in the 
microspheres at the end of the process (Fig. 1). For this reason there is no uniform 
final Tg value. The particles prepared at 10 °C with the highest amount of residual 
solvent (3.46%) show the lowest Tg (21.6 °C) at the end of the process and the 
particles prepared at 35 °C with only 0.93% residual solvent exhibit the highest Tg of 
34 °C after 5 hours.  
The variation of the process temperature strongly determines the properties of the 
resulting microsphere. This is attributed to the flexibility of the polymer chains during 
processing. After 10 minutes the Tg of the particles prepared at 10 °C is already 
above the process temperature. Thus the polymer matrix becomes rigid and 
immobile and its structure is fixed within the first minutes of the process, resulting in 
a sponge-like morphology of the microspheres and a porous surface (Fig. 5a). A 
higher preparation temperature prolongs the time span, in which the process 
proceeds above the glass transition temperature. By applying a preparation 
temperature of 20 °C the polymer is in a rubbery state for the first 50 minutes of the 
process and this time span becomes more and more extended for the batches 
prepared at higher process temperatures. At 35 °C the Tg does not exceed the 
preparation temperature at all during the total 5 hours of processing, leading to 
microspheres with a dense outer layer, a smooth surface and a fine porous structure 
inside (Fig. 5b). This does not agree with the findings of Fu et al, who observed the 
opposite effect, i.e. a highly porous structure at high temperatures and a smooth 
surface at low temperatures [17]. In case of other ingredients, like a low molecular 
PLGA as used by Fu et al. these conditions might lead to other morphological 
properties. 
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Figure 5: SEM micrographs of microspheres prepared at 10 °C (a) and 35 °C (b) 
3.2.2 Influence on the encapsulation efficiency and molecular weight 
In this investigation the highest drug encapsulation efficiency was found at low 
process temperatures of 10 and 20 °C and decreased with rising temperature of the 
external phase (Fig. 6b). Graves et al found that the encapsulation efficiency is 
significantly influenced by the rate of polymer precipitation [18] and thus also by the 
applied preparation temperature. A fast solidification rate is considered to be 
beneficial for a high entrapment of drug substance. Whereas Yang et al. found the 
best encapsulation efficiency for the lowest and highest formation temperatures [19] 
we obtained the best encapsulation efficiency between 93 and 96% of the 
introduced drug substance only at low process temperatures. At higher process 
temperatures of 27.5 °C and above we obtained a sharp decrease in the 
encapsulation efficiency with a minimum of 80% for 30 °C. 
Not only the temperature of the external phase but also the phase ratio of dispersed 
and continuous phase is an important parameter for the fast precipitation of the 
polymer. As the amount of the dispersed phase is very low (1:100), the solidification 
rate is very fast even for low preparation temperatures. Soon after mixing both 
phases the Tg of the polymer exceeds the process temperature leading to a slower 
diffusion rate of the dissolved drug substance in the polymer matrix and thus 
favouring the drug entrapment. By applying a higher temperature the polymer 
molecules stay flexible and the drug molecules can diffuse through this soft matrix 
into the external phase resulting in reduced encapsulation efficiency. 
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Besides the encapsulation efficiency the polymer molecular weight of the resulting 
microspheres is influenced by the applied process temperature. As expected, it 
decreased with increasing process temperature, as the hydrolysis of PLGA is 
accelerated by rising temperature [20]. No significant temperature dependence of 
the degradation rate could be detected between 10 and 27.5 °C. Within this 
temperature range the molecular weight drops during the process from the initial 
value of 56.0 kDa by an average of approximately 2.0 kDa. A sharp further decline 
occurs between 30 and 35 °C with a decrease by up to 5.5 kDa which is about 10% 
of the initial value. The degree of polymer degradation correlates with the time span 
during which the process temperature exceeds Tg. In other studies even more 
dramatic weight losses during the time of process temperature above the Tg of the 
polymer have been reported [21]. Thus the process temperature not only affects the 
glass transition temperature and structure formation but also clearly leads to 
differences in the molecular weight. For all these factors the process temperature 
and the process time below and above the Tg appear to be crucial. 
 
Figure 6:  Influence of the preparation temperature on the encapsulation efficiency (a) and the 
molecular weight (b) of the resulting microspheres 
3.2.3 Influence on the drug release rate 
The drug release from PLGA microspheres is influenced by a variety of process 
parameters in an emulsion solvent removal process [22, 23] and by the resulting 
morphology of the microspheres [24]. Su et al. studied the influence of the 
homogenization speed, the molecular weight of PLGA and PVA and the PLGA 
concentration on the drug release profiles of microspheres at room temperature 
[25]. Among all the process parameters in an emulsion solvent extraction process, 
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the temperature during formation and hardening of the microspheres must have a 
crucial impact on the resulting drug release profile. 
 
Figure 7: Drug release profiles of the microspheres prepared at 10 °C (--), 20 °C (--), 27.5 °C    
(--), 30 °C (--), 32.5 °C (-+-) and 35 °C (--) (37 °C and pH 7.4) 
The particles prepared at 10 °C showed an almost linear release of the drug 
substance (Fig. 7). Process temperatures of 20 °C and above caused more and 
more sigmoidal profiles. They start with a lag phase without any significant drug 
release, followed by a second phase with an accelerated release rate. The higher 
the applied process temperature the more pronounced is the lag phase and the 
sigmoidal drug release profile. At a process temperature of 30 °C the lag-phase 
reached a maximum of 15 days which was prolonged by applying higher 
temperatures.  
As discussed before, at a preparation temperature of 10 °C the polymer matrix is not 
exposed to a temperature above its Tg resulting in microspheres with a sponge-like 
porous structure without any visible shell (Fig. 5a). As a result, water can rapidly 
penetrate into the microspheres and dissolve the drug substance out of the polymer 
matrix. Simultaneously degradation of the polymer matrix starts throughout the 
whole particle. This causes a bulk erosion of the microspheres as described by 
Burkersroda et al. [26]. From a certain point in time the drug release is a result of 
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both, drug diffusion and erosion of the polymer matrix. Because of the open-porous 
structure the degradation products of the polymer hydrolysis diffuse out of the 
particles into the surrounding medium. This impedes the accumulation of these 
acidic hydrolysis products inside the microspheres which otherwise would cause an 
autocatalytic acceleration of the degradation process [27]. For this reason the drug 
release does not achieve the rate of the particles with a denser structure. 
When the solvent extraction is performed at 20 °C the process temperature exceeds 
the Tg of the microspheres for about 50 minutes. Thus a more compact structure is 
formed and the drug release does not start before day 5. The higher the applied 
preparation temperature, the longer the polymer matrix is exposed to a temperature 
above its Tg. In case of the batch prepared at 35 °C the Tg does not reach the 
preparation temperature for the entire process. The polymer chains are flexible and 
mobile and the polymer matrix remains in a rubbery state. A dense structure is 
formed during processing, which has a crucial impact on the lag-phase and the 
release characteristic of the resulting microspheres (Fig. 5b). The small water 
molecules can diffuse through the dense matrix into the microspheres and 
hydrolysis of the polymer chains starts. As the resulting fragments of the polymer 
chains cannot diffuse out of the particles, their accumulation leads to a significant 
drop of the pH in the interior of the spheres [27]. This drop of the pH accelerates the 
polymer degradation and at a certain molecular weight, mostly between 10000 and 
15000 Da the drug release rate strongly increases [28]. Furthermore the pH drop 
leads to a better solubility of the drug substance. 4-[2-[4-(6-fluorobenzo[d]isoxazol-
3-yl)-1-piperidyl]ethyl]-3-methyl-2,6-diazabicyclo[4.4.0]deca-1,3-dien-5-one is only 
poorly soluble at neutral pH (0.06 mg/ml), but its solubility increases considerably 
with decreasing pH to 10.91 mg/ml at pH 3. Thus not only the diffusion coefficient 
within the polymer is increased by acidic degradation but also the concentration of 
the saturated drug solution in the core of the particles rises as a result of the 
acidification. According to Fick’s first law of diffusion both factors increase the 
diffusion flux of drug out of the particles. For these reasons a dense structure is 
essential for a sigmoidal drug release profile with a lag-phase and subsequent fast 
drug release, whereas a porous outer surface of the microspheres leads to an 
almost linear drug release profile from the beginning of the dissolution testing. 
Plotting the lag time against the time interval in which the process takes place above 
the Tg (tTp > Tg) suggests, that a distinct change in microparticle morphology, which 
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is caused by treatment at temperatures above Tg, determines the length of the lag 
phase (Fig.8).  
 
Figure 8: Lag-time of drug release vs. period of time during which processing takes place above 
the Tg of the polymer (tTp>Tg) 
In addition to the time span, the process takes place above the Tg of the polymer 
also the difference between the applied process temperature and the Tg at a certain 
point in time might influence the resulting morphology of the particles. For this 
reason the area between the curves for the process temperature and the Tg was 
calculated by integration. The larger this area, the more pronounced is the 
difference between the applied process temperature and Tg of the microspheres. 
Figure 9 shows the correlation between the integral of the temperature by which Tp 
exceeds Tg and the lag-time before drug release. The diagram reveals a positive 
correlation between the integrated temperature difference and the lag-time.  
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Figure 9:  Lag-time depending on the integral of Tp and Tg  
3.2.4 Influence of the polymer chain length 
The molecular weight of the employed PLGA has a strong influence on the 
encapsulation efficiency and the drug release rate of microspheres [29]. Su et al 
found, that the encapsulation efficiency increased with higher molecular weight of 
the polymer [25]. In other cases, depending on the drug to be encapsulated, a low 
molecular weight polymer could be more appropriate for a high drug load [17]. As 
the length of the polymer chains has an impact on the resulting morphology of the 
polymer matrix, the molecular weight has also an influence on the drug distribution 
and release rate from the microspheres. Fu et al. found, that a high molecular 
weight leads to a high initial burst and a subsequent slow release, whereas the use 
of a low molecular weight PLGA resulted in a fast drug release. This effect occurs in 
addition to the impact that the polymer degradation itself has on drug release. 
We investigated the influence of the molecular weight on the solidification rate of the 
polymer matrix measured by the change of the glass transition temperature during 
particle formation. 
Although the molecular weight of the applied polymers ranged from 36.5 to 
109.2 kDa no differences in the Tg vs. time profiles at a manufacturing temperature 
of 35 °C could be observed (Fig. 10). 
CHAPTER 5                                                                                                                                                
 110 
 
Figure 10: Tg vs. time profiles from particle preparations using PLGA types of different molecular 
weight (36510 Da (--), 58300 Da, (--), 109200 Da(--)) at a process temperature of 
35 °C. 
However there is a significant influence of the molecular weight on drug release. 
The fastest release was obtained for the polymer with the lowest molecular weight 
(Fig. 11). 
 
Figure 11: Drug release profiles of the microspheres prepared at 35 °C with PLGA types of 
different  molecular weights (36510 Da (--), 58300 Da (--), 109200 Da (--)) 
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The drug release starts after 13 days for the 36510 Da PLGA and thus about 4 days 
earlier compared to the batch prepared with 58.3 kDa PLGA. This is due to the fact, 
that the low molecular weight PLGA exhibits enhanced water permeation and 
accelerated erosion of the polymer matrix. The lag-time is followed by a steep 
incline of the curve during the erosive phase of the drug release. The microspheres 
prepared with 109.2 kDa PLGA showed an only marginally changed drug release 
profile compared to the batch prepared with 58.3 kDa PLGA. The only small 
difference in lag-phase of the particles prepared with 109.2 kDa PLGA and those of 
58.3 kDa PLGA can be referred to the fact, that the degradation of the high 
molecular weight polymer during processing is much more pronounced, resulting in 
particles 70.5 kDa compared to 54.7 kDa after manufacturing. 
3.2.5 Influence of solvent removal rate  
As mentioned above, the flexibility of the polymer chains during processing has a 
strong influence on the resulting particle morphology and it depends, inter alia, on 
the solvent content of the polymer phase. The higher the amount of solvent in the 
polymer matrix, the lower its Tg. A decelerated solvent evaporation can be achieved 
by reducing the stirring speed and the air flow through the reactor (Tab. 2).  
Table 2: Process parameters and properties of microspheres prepared at 35 and 32.5 °C 
with fast and slow solvent evaporation 
Process 
temperature [°C] 
Stirring 
speed 
[rpm] 
Air flow 
[l/min] 
Encapsulation 
efficiency [%] 
Molecular weight end 
of process [kDa] 
35 260 10 81.8 50.7 
35 180 1.5 79.3 44.9 
32.5 260 10 80.4 51.0 
32.5 200 1.5 44.7 51.5 
 
At a process temperature above 30 °C such conditions lead to a prolonged interval, 
during which the process proceeds above the Tg of the particles (Fig. 12). The 
change of the glass transition temperature in case of slow solvent removal was 
significantly decelerated compared to fast evaporation. The particles prepared at 
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32.5 °C and slow solvent evaporation showed an almost linear increase of the Tg 
from 8 °C at the beginning to 32 °C after 5 hours of processing. 
 
Figure 12: Tg vs. time profiles during processing at 32.5 °C (left) and 35 °C (right) with fast (--) 
and slow (--) solvent extraction according to Tab. 2 
At 35 °C the slow solvent extraction leads to a marked amplification of the polymer 
degradation during processing (Tab. 2). The encapsulation efficiency was hardly 
affected in case of the batch prepared at 35 °C, whereas in the case of the batch 
prepared at 32.5 °C only half of the drug substance was encapsulated, if the 
evaporation was slowed down. The microscopic pictures revealed that no spherical 
but irregular shaped and broken particles were obtained under these process 
conditions. With a very slow removal of the organic solvent and thus a delayed skin 
formation on the particle surface the preparation process can become unstable. 
During processing the organic solvent diffuses from the liquid emulsion droplets or 
hardening particles into the surrounding extraction medium. Consequently 
solidification starts from the surface of the particles and at the beginning of the 
process a highly viscous outer shell is formed, which covers the liquid core of the 
particle. This outer shell is still fragile and with a rising vapor pressure of the solvent 
the shell can be ruptured, releasing parts of the enclosed liquid into the surrounding 
medium. This causes a high drug loss during processing. In former experiments 
even the precipitation of drug crystal needles could be observed (data not shown). 
Thus a certain rate of particle solidification is essential to minimize the length of this 
vulnerable stage of the solidification process and to obtain intact microspheres with 
a high drug load.  
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3.2.6 Influence of a subsequent resuspension of the particles with 
ethanol 
In addition, we studied the effect of a terminal ethanolic resuspension step on the 
resulting particle characteristics. Ahmed et al. showed that the treatment of the wet 
microparticles with an organic solvent/water mixture and adding solvents into the 
external aqueous phase changed the microstructure of the particles [30]. It caused 
the reduction of pores and thus reduced burst release. After 5 hours of extraction at 
35 °C the microspheres were filtrated, immediately suspended in an ethanol/water 
mixture (25:75 (v/v)), and heated up to 25 °C or 40 °C, respectively. Ethanol is a 
non-solvent for PLGA and only a poor solvent for the encapsulated drug. By 
diffusing into the polymer matrix it can act as a plasticizer and lower the Tg of the 
polymer. This was confirmed experimentally as a slight reduction of Tg from 33 °C to 
29 °C after 1 hour was measured. Thus, depending on the applied preparation 
temperature, a further change in the structure of the polymer matrix can be 
expected. 
In all samples which were treated with ethanol the degradation of the polymer was 
more pronounced in consequence of the prolonged processing time (Tab. 3). The 
treatment of the microparticles with 25% ethanol at 40 °C caused an extreme drug 
loss. Only about 60% of the drug substance employed was encapsulated. In 
contrast particles treated at 25 °C showed an encapsulation efficiency of more than 
80%, comparable to the microspheres without ethanol treatment. 
Table 3: Preparation parameters and characteristics of microparticles treated with 
ethanol/water mixture (25:75) at different temperatures 
Temperature 
[°C] 
Duration 
[min] 
Encapcusulation 
efficiency [%] 
Molecular weight 
[Da] 
Lag phase 
[d] 
40 60 60.50 48930 17 
40 120 61.44 45390 17 
25 60 80.27 49750 14 
The microspheres showed a lag phase of 14 days when treated with ethanol for 1 
hour at 25 °C. Incubation at 40 °C caused a change to a triphasic pattern. A lag 
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phase of 17 days is followed by a slightly increased drug release up to 10% and 
finally a very fast release after 18 or 26 days, respectively (Fig. 13).  
 
Figure 13:  Drug release profiles of the microspheres treated with ethanol-water-mixtures for 1 hour 
at 40 °C (--), 2 hours at 40 °C (--), and 1 hour at 25 °C (--)  
The particles treated with 25% ethanol at 25 °C had a similar shaped drug release 
profile as particles without this pretreatment. Due to the decreased molecular weight 
(49750 Da) the profile lies between the curves of non-incubated particles made from 
a 36510 Da PGLA and those made from a 58300 Da PLGA. At 25 °C the Tg was not 
exceeded by the process temperature and thus, besides the increased polymer 
degradation, no structural changes could occur. 
Compared to the untreated microspheres those particles treated with ethanol at 
40°C showed a thick and dense outer shell (Fig. 14). Chemical imaging revealed 
that this shell was almost completely free of drug (Fig. 15).  
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Figure 14:  SEM micrographs of microparticles after treatment with ethanol (25%) at 40 °C after 1 
(a) and 2 hours (b) and without treatment (right) 
Hindrance of diffusion by this low porous shell is to be considered as the cause of 
the extended lag-phase after ethanol incubation at elevated temperature. 
 
Figure 15: Chemical imaging of the microparticles: distribution of PLGA in the particles (white 
coloured area = high adsorption at 1747 cm-1 (characteristic band for PLGA)) 
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4 Conclusions 
The effects of different process parameters on the characteristics of PLGA 
microspheres were investigated with a focus on the processing temperature. The Tg 
of the polymer was used to measure the flexibility of the polymer chains during 
processing. The Tg depends on the amount of organic solvent in the polymer matrix 
and can also be affected by other molecules like water or drug substance. A good 
correlation can be found for the concentration of organic solvent and the decrease 
of the Tg if no drug substance is present. A linear correlation cannot be found for 
drug loaded particles, indicating a synergistic effect of the solvent and the drug 
substance dissolved in the polymer phase. 
The encapsulation efficiency and the drug release can be distinctly modified by 
changing the preparation temperature. This is due to the fact that particles prepared 
at 10 °C show an open porous structure, whereas a higher temperature leads to the 
formation of a dense matrix and a smooth surface, impeding a diffusive drug release 
at the beginning of the dissolution testing. Consequently, in case of a shell structure, 
the degradation products cannot diffuse out of the microspheres. This induces a 
significant pH-drop inside the particles with the occurrence of autocatalytic effects 
and enhanced drug solubility. 
The time span during which the polymer chains remain flexible, which can be 
recognized by a Tg higher than the process temperature, can be modified by a 
slower removal of the organic solvent. If the solvent removal is carried out too slowly 
the process can become instable resulting in irregularly shaped and broken 
microspheres. A certain rate of solidification is essential to obtain spherical 
microspheres with efficiently encapsulated drug substance.  
The slow release of a poorly soluble drug substance from a PLGA matrix is 
influenced by the chain length of the applied polymer. Further modifications can be 
obtained by the formation of different structures of the polymer matrix. For this 
reason a good control of the Tg during processing is essential, as its change has a 
strong influence on the resulting microsphere morphology. A precise control of the 
process temperature and the solvent removal rate are necessary which is often not 
possible on a laboratory batch scale. Depending on the process time during which 
the polymer chains remain flexible and mobile, the structure of the polymer matrix 
can be coarse- and open-porous or fine-porous with a dense outer shell. Thereby 
  CHAPTER 5 
 117 
the drug release varies between an almost zero-order-release to a sigmoidal type of 
the curve with a distinct lag-time. The latter mentioned profile was particularly 
marked for particles prepared with an additional suspension step in an ethanol water 
mixture. This caused a softening of the polymer matrix and the formation of a dense 
outer shell. However it should be pointed out, that this change of the morphology 
occurred on the expense of the drug load. 
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CHAPTER 6 
A novel method for the determination of the 
intraparticulate pore volume and structure of 
microspheres ‡ 
 
Abstract 
The objective of this work was to develop a fast and significant method for the 
determination of the intraparticulate pore size distribution of microspheres. 
Poly(lactide-co-glycolide (PLGA) microspheres prepared with a solvent 
extraction/evaporation process were studied. From the envelope and the skeletal 
volume of the microspheres the porosity was calculated. The skeletal volume was 
determined with nitrogen and helium pycnometry and mercury intrusion porosimetry. 
Based on single particle optical sensing (SPOS) a novel method was developed by 
which the envelope volume is calculated from the particle size distribution (PSD), 
provided that all particles have a spherical shape. The penetration capacity of the 
applied intrusion media is limited by their atomic or molecular diameter or by the 
surface tension and the pressure in case of mercury. A classification of the pore 
structure was obtained by comparing these different skeletal values with the values 
for the envelope volume. Two well separated pore fractions were found, a 
nanoporous fraction smaller than 0.36 nm and a macroporous fraction larger than 
3.8 µm. The total porosity and the ratio between both fractions is controlled by the 
preparation process and was shown to depend on the solvent extraction 
temperature.  
 
‡
Published in International Journal of Pharmaceutics 2010, 402 (1-2), 20-26. Vay,K.; Scheler,S.; 
Friess,W., New insights into the pore structure of poly(D,L-lactide-co-glycolide) microspheres. 
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1 Introduction 
Porous materials have found widespread use in many pharmaceutical and also 
technical applications, such as ion exchangers, adsorbents, chromatographic 
packings, supports for heterogeneous catalysis or solid-phase synthesis. Because 
of rapid advances in controlled drug delivery and tremendous growth of fields like 
solid phase catalysis and separation science, research on these kinds of materials 
has experienced a considerable uptrend in recent years. In all these applications the 
pore texture of the material is a crucial factor for its functionality and has to be 
optimized for the intended purpose. In many applications, for example, a bimodal 
pore size distribution is desirable with a network of large pores providing the 
pathways for an efficient mass transport and small pores providing a large active 
surface [1, 2]. Numerous porous materials are designed in the form of 
microspheres, frequently manufactured via emulsification or spray drying processes. 
In case of microspheres for pharmaceutical use, the porosity has significant 
influence for example on drug release [3-8]. In other applications of microspheres 
where the pore texture is sometimes considered not to be a principal feature, 
porosity is at least an important quality characteristic and its significance is often 
underestimated. 
In general the porosity describes the fraction of voids in a given volume of a 
material. Depending on the size and type of pores included by the measurement 
different values can be derived [9]. This fact is also reflected in the existence of 
different definitions of porosity. The American Society for Testing and Materials 
(ASTM) defines it as “the ratio, usually expressed as a percentage, of the total 
volume of voids of a given porous medium to the total volume of the porous 
medium” [10], whereas the British Standards Institution (BSI) describes it as “the 
ratio of open pores and voids to the envelope volume [11]. Thus a given porosity 
value has to be interpreted in consideration of (i) the range limits of the measuring 
method and (ii) the inclusion or exclusion of open pores. Especially in case of 
dispersed solids the precise determination of the particles’ envelope volume is a 
difficult and often unsolved problem. Many intrusion media even mercury under low 
pressure were found to fill not only the interparticular voids but to penetrate also into 
open pores to a certain extent. Various approaches have been made to overcome 
this problem e.g. subtraction of the interparticular volume of crushed nonporous 
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glass beads from the total void volume of the porous sample particles, both 
measured by mercury intrusion [12]. 
Mercury intrusion porosimetry is a common method to determine the porosity of a 
material and provides also information about its pore size distribution [13]. Mercury 
is a non-wetting, non-reactive liquid, which will not penetrate into small pores until a 
certain pressure is applied. The relationship between the pressure and the pore 
size, into which mercury is able to intrude, is given by the Washburn equation. It 
permits to acquire data over a broad range of pore diameter up to 360 µm, but 
implies several problems as well. Besides the difficulty to distinguish between intra- 
and interparticulate porosity as aforementioned, the measurement requires a toxic 
substance, relatively large sample quantities and is time-consuming. Furthermore 
ink-bottle shaped pores and interconnected pores shift the pore size distribution to 
smaller pores and bias the results [14, 15]. 
Another technique to gain information about the porosity is nitrogen adsorption. 
Beyond the specific surface area of the sample further textural characteristics can 
be derived from adsorption-desorption isotherms of nitrogen at its boiling point. 
However, only the micro- and mesoporous range of the pore distribution is covered 
by this method. Further approaches to determine the porosity are the water 
saturation [16] and water evaporation technique [17]. In these methods the sample 
is allowed to equilibrate with an excess of water. The total volume minus the amount 
of the not absorbed water reflects the volume of the pore space. If water is able to 
cause swelling of the sample, these methods do not allow distinguishing between 
permanent and temporary porosity. 
Despite their widespread use all these techniques lack in accuracy and/or simplicity 
and are not able to distinguish between intra- and interparticulate pores. As 
mentioned before, the porosity can be calculated from the envelope and the skeletal 
density of the material. Gaspycnometry is an accurate method to determine the 
latter parameter, whereas the measurement of the apparent density is often difficult 
in case of a dispersed material. For this reason we developed a novel method for 
the determination of the intraparticulate porosity using single particle optical sensing 
(SPOS). This particle sizing method enables to determine the envelope volume of 
dispersed particles with high accuracy, provided that all particles have a spherical 
shape. The intraparticulate porosity ε is defined as: 
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As mentioned before the use of different intrusion media allows gauging different 
fractions of the total pore volume. The different pore fractions in a material can be 
classified according to IUPAC into micropores, smaller than 2 nm, mesopores 
ranging from 2 to 50 nm and macropores, bigger than 50 nm [18]. The volume 
occupied by helium is assumed to be the total pore volume and the difference to the 
envelope volume is therefore the skeletal volume of the material. With nitrogen and 
mercury lower pore volumes are obtained corresponding to the diameter of the 
smallest pores into which the respective medium is able to penetrate. By comparing 
these values detailed information about the pore size distribution and the 
morphological structure can be gained. In the presented study this method was 
evaluated for porosity and structure analysis of poly(lactide-co-glycolide (PLGA) 
microspheres prepared via an emulsion solvent extraction/evaporation process.  
2 Materials and Methods 
2.1 Materials 
Poly (D,L-lactide-co-glycolide) 75:25 (Resomer 755 S): Mw = 64710 Da was 
purchased from Boehringer Ingelheim, (Ingelheim, Germany); Poly (D,L-lactide-co-
glycolide) 75:25 (Lactel) in granuled form was purchased from Durect Corporation 
(Pelham, USA); 3-{2-[4-(6-fluor-1,2-benzisoxazol-3-yl)piperidino]ethyl}-2-methyl-
6,7,8,9-4-H-pyrido[1,2-a]pyrimidin-4-one was obtained by Jubilant Organosys 
(Mysore, India). Polyvinylalcohol 26-88 and methylene chloride analytical grade 
were obtained from Merck (Darmstadt, Germany), TRIS (Tris(hydroxymethyl)-
aminomethan) from AppliChem (Darmstadt, Germany) and Polystyrene research 
particles (Mean diameter 98.7 µm ±1 µm) from microParticles GmbH (Berlin, 
Germany). 
2.2 Microparticle preparation 
The microparticles were prepared by an emulsification, solvent 
extraction/evaporation technique. 2.8 g drug substance and 3.2 g PLGA were 
dissolved in 40 ml of methylene chloride. The polymer solution was then emulsified 
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in 500 ml of the exctraction medium consisting of an aqueous solution of 0.5% (w/v) 
polyvinylalcohol and 0.1 M Tris buffer (pH 9.0). The emulsion was than feeded into a 
5 L jacketed glass reactor containing 3.5 L of the aqueous phase. By stirring for 5 
hours the particles were hardened by solvent extraction and evaporation with an air 
flow of 10 l/min through the headspace of the reactor. The particles were separated 
by filtration and dried under vacuum in a desiccator. Different particle batches were 
produced by varying the temperature of the extraction mix between 10 and 35 °C. 
2.3 Analytical methods 
2.3.1 Single particle optical sensing (SPOS) - light obscuration 
The particle size distribution was measured with an AccuSizer 780 (Sensor: LE400-
05SE; Particle Sizing Systems, Santa Barbara, CA). This instrument uses the 
principle of light obscuration to count and size particles from 0.5 to 400 µm. The 
data is obtained in 512 logarithmically spaced channels with a minimum and 
maximum fraction width of 1 to 5.54 µm. Per measurement about 10 mg of 
microparticles were weighed exactly into a particle free vessel and dispersed in 100 
ml particle free 1% Polysorbate 80 solution. For exact results it is essential, that the 
complete suspension is analyzed. In the case of spherical particles the total volume 
of a sample can be calculated from the particle size distribution. For every particle 
size fraction the average volume of a single particle was calculated with the sphere 
volume formula from the average diameter di of each fraction range. The total 
volume of all particles within a fraction was obtained by multiplication with the 
number ni of particles within the respective size class. With the sum of the volumes 
of all 512 size fractions and the sample weight m the envelope density ρenv was 
computed. 
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2.3.2 Gas pycnometry 
The skeletal density was measured using helium pycnometry (Ultrapycnometer 
1000, Quantachrome GmbH, Odelzhausen, Germany ). The samples were dried in 
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an air flow of 3% r.h. for at least 72 hours and about 500 mg particles were weighed 
into the medium size sample holder (volume 1.8 cm³). The density of the sample 
was additionally measured with nitrogen. 
2.3.3 Mercury intrusion porosimetry 
In order to cover a wide pore range the mercury intrusion measurements were 
performed with both a high- and a low-pressure unit. As low-pressure-unit a Pascal 
140 porosimeter (Thermo Fisher Scientific, I-Milano; pressure range: 0.01 to 
400 kPa) and as high-pressure-unit a Porosimeter 2000 (Carlo-Erba, I-Milano; 
maximum pressure: 200 MPa) were utilized. 
2.3.4 Specific surface area 
The specific surface area was determined by analyzing a sample of approx. 350 mg 
by a BET method (multi-point measurement) using a Nova 2000e surface analyzer 
(Quantachrome GmbH, Odelzhausen, Germany). Before the measurement the 
samples were degassed for 1 hour at 40 °C. 
2.3.5 Scanning electron microscopy  
Cross sections of the microspheres were examined by scanning electron 
microscopy (JEOL JSM – 5310LV; JEOL Ltd., Tokyo, Japan). To study the internal 
structure, the particles were frozen in liquid nitrogen and cut with a razor blade. The 
specimens were sputtered with gold.  
3 Results 
A first impression of the inner structure of the microspheres can be obtained by gas 
pycnometry. Preliminary experiments showed that it is essential to dry the samples 
completely. By purging the sample for incremental periods with the measuring gas 
in the sample cell of the pycnometer the moisture is slowly removed and 10 hours of 
purging are necessary to reach constant readings (Fig. 1).  
In many samples, due to their microporosity, densities measured with nitrogen were 
lower than those measured with helium, corresponding to different molecule and 
atom sizes of the gases. Without pre-drying the difference between both 
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measurements does not become apparent. Since the microspheres are not 
thermally stable an air flow of 3% r.h. was applied for at least 72 hours to dry the 
samples at room temperature prior to gas pycnometry.  
 
Figure 1: Density of PLGA-microspheres as a function of drying time with dry gas flow of helium 
() and nitrogen gas () 
In order to estimate the skeletal density of the polymer matrix, pure PLGA in 
different morphological forms was measured as a reference material with helium 
and nitrogen pycnometry (Tab. 1). 
Table 1: Density of PLGA in different morphologies measured with helium and nitrogen 
pycnometry 
Measuring gas Helium Nitrogen 
Sample 
Density 
[g/cm³] 
density 
[g/cm³] 
PLGA, powder 1.2468 1.3831 
PLGA, tablet * 1.3071 1.2884 
PLGA, granules 1.3018 1.2893 
PLGA, microspheres (process temperature : 35 °C) 1.3046 1.2755 
Polystyrol microparticles 1.0516 1.0536 
* compressed with a compactor for IR spectroscopy 
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The values of the granulated and tableted PLGA and the placebo microspheres 
showed only slight differences between the measurements with both gases yielding 
a skeletal density of 1.3045 ± 0.0027 g/cm³ for helium and 1.2844 ± 0.0077 g/cm³ 
for nitrogen. Only the PLGA powder revealed a lower density for helium and an 
unexpected high value for nitrogen.  
In the same way the microspheres prepared with varying process temperatures 
were analyzed (Tab. 2). 
 Table 2: Density and specific volume of PLGA microspheres prepared at different process temperatures 
 
Intrusion 
medium 
Helium Nitrogen Mercury (at 350 kPa) 
Formulation 
Process 
temperature 
[°C] 
Density 
[g/cm³] 
Specific 
volume [cm³/g] 
Density 
[g/cm³] 
Specific 
volume [cm³/g] 
Density 
[g/cm³] 
Specific 
volume [cm³/g] 
1 10°C 1.2834 0.7792 1.2784 0.7822 1.335 0.7491 
2 20°C 1.2800 0.7813 1.2554 0.7966 1.236 0.8091 
3 30°C 1.2719 0.7862 1.1827 0.8455 1.164 0.8591 
4 32.5°C 1.2763 0.7835 1.1983 0.8345 1.178 0.8489 
5 35°C 1.2853 0.7780 1.1841 0.8445 1.203 0.8313 
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The incorporated drug substance reduced the nitrogen pycnometric density more 
than 0.09 g/cm³ below the density of the placebo microspheres. In contrast the 
densities measured with helium showed rather identical values differing only about 
0.02 g/cm³ from the placebo density. Using helium, the densities ranged between 
1.2719 and 1.2853 g/cm³, whereas the nitrogen pycnometric values cover a larger 
range from 1.1827 to 1.2784 g/cm³. The differences between the helium and the 
nitrogen pycnometric results depend on the temperature applied in the preparation 
process and ranged from 0.005 g/cm³ (10 °C) to 0.1 g/cm³ (35 °C).  
As a second parameter in equation 1 the envelope volume of the material is 
required for the calculation of the intraparticulate porosity. Taking advantage of the 
particles’ spherical shape a method was developed to obtain the specific envelope 
volume and its reciprocal value, the envelope density, by optical particle counting 
and size fractionation of a known sample weight. In order to prove the accuracy 
monodisperse polystyrene microparticles with a mean diameter 98.7 ± 1 µm were 
analyzed. In case of these nonporous spherical particles the bulk density can be 
assumed to equal the true density of the particles. According to manufacturer´s data 
the true density of the polystyrene particles is 1.05 g/cm³. By gaspycnometry a value 
of 1.0518 ± 0.0012 (n = 5) was obtained and with SPOS a density of 1.0427 ± 
0.0149 (n = 4) was calculated, which means a deviation of less than 0.7%. 
The PLGA microspheres of formulations 1 to 5 were found to have similar particle 
size distributions with median diameters (volume weighted) between 80 and 90 µm 
(Tab. 3). 
Table 3: Volume weighted median diameter measured with SPOS and calculated 
envelope volume and bulk density  
Process 
temperature [°C] 
Median [µm] 
Specific envelope 
volume [cm³/g] 
Envelope density 
[g/cm³] 
10 82.725 0.950 1.053 
20 84.445 0.970 1.031 
30 82.270 0.959 1.043 
32.5 86.835 1.014 0.988 
35 87.100 1.035 0.972 
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This corresponds well with the photomicrographs shown in Fig.2. The calculated 
envelope densities varied between 0.972 to 1.053 g/cm³ with higher values in case 
of smaller particles. The envelope density decreased with rising process 
temperatures, following a trend which can also be observed in nitrogen pycnometry. 
 
Figure 2: SEM of PLGA microspheres prepared at 10°C (top) and 35°C (bottom) 
The density measured by low pressure mercury intrusion porosimetry did not show 
continuous temperature dependence. (Tab. 2) The values exceeded the envelope 
densities by about 0.1 to 0.3 g/cm³ thus indicating, that even under the conditions of 
low pressure Hg-porosimetry (350 kPa) mercury penetrates into the particles and 
consequently the values do not correctly represent the envelope volume of the 
microspheres. 
The surface area of formulation 5 was determined by nitrogen adsorption. Although 
SEM photomicrographs revealed a highly porous structure, the value for the surface 
area of 0.41 m²/g was unexpectedly low. 
CHAPTER 6                                                                                                                                                
 132 
4 Discussion 
4.1 Interparticulate volume 
The main focus of this investigation was the intraparticulate volume. However, a 
bulk material like microspheres contains also another type of voids: the 
interparticulate space. Figure 3 shows the mercury intrusion-extrusion curve of 
monodisperse polystyrene spheres with a diameter of 98.7 µm.  
 
Figure 3: Intrusion - extrusion curve of monodisperse polystyrene microspheres (Ø 98.7 ± 1 µm) 
The intruded mercury fills the interparticulate space until its volume reaches a 
plateau value of 0.603 cm3/g at 100 kPa. This pressure corresponds to a pore 
diameter of 17 µm which is exactly 1/6 of the particle diameter, the value expected 
on basis of a consideration of Tonellier [12]. He reports that the diameter of voids 
between monodisperse spheres is about 1/6 of the particle diameter. It can be 
concluded that it is even smaller in case of a heterogenous size distribution where 
small particles fill the voids between larger ones. The small slope of the plateau can 
be attributed to a pressure-induced deformation of the polymer structure. It leads to 
an intrusion volume of 0.618 cm3/g at 350 kPa, the pressure which was found 
necessary to fill also the interparticulate voids between the smaller particles of the 
PLGA formulations. The sum of this intrusion volume and the specific volume of the 
polystyrene spheres measured at the same pressure of 350 kPa (0.929 cm3/g) is 
the bulk volume of the particle bed (1.547 cm3/g). Its packing density, 61.99%, is 
obtained as the ratio of the envelope volume, determined by the SPOS method 
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(0.959 cm³/g), and the bulk volume (0.959 cm³/g / 1.547 cm3/g = 61.99%). In case of 
non-porous particles about the same value can also be obtained from mercury 
porosimetry data only as the ratio of the specific volume and the bulk volume 
(0.929 cm3/g / 1.547 cm3/g = 60.05%). Both results are close to the maximum 
random packing density of monodisperse spheres which was calculated as 64.35% 
[19]. As discussed before, in case of porous PLGA microspheres the mercury 
intrusion volume covers the interparticulate voids in addition to a certain part of the 
intraparticulate pores (> 3.9 µm at 350 kPa). The specific volume measured at the 
same mercury pressure is the skeletal volume plus the remaining pore volume 
(< 3.9 µm). Table 4 shows the mercury intrusion volume, the specific volume (both 
determined at 350 kPa), and the bulk volume of formulation 1-5.  
Table 4: Intrusion, specific and bulk volume for formulation 1-5 and the resulting  
packing density 
Formulation 
Intrusion volume 
[cm³/g] 
Specific volume 
[cm³/g] 
Bulk volume Packing density
1
 
at 350kPa at 350 kPa [cm³/g] [%] 
1 0.5292 0.7491 1.2782 74.32 
2 0.5159 0.8091 1.3249 73.21 
3 ─ 0.8591 ─ ─ 
4 0.5478 0.8489 1.3968 72.59 
5 0.6017 0.8313 1.4327 72.24 
1
 Packing density = specific envelope volume (from Tab.3) / bulk volume 
The difference to 100% is the share of the interparticulate voids in the total bulk 
volume. The particles of all formulations are about the same size and log-normal 
distributed with a standard deviation of 0.26 to 0.36. According to Farr the maximum 
packing fraction of a log-normal sphere distribution depends on its standard 
deviation σζ and amounts to 67-68% for the mentioned range of σζ. Because of the 
intraparticulate porosity it is not surprising to find values smaller than theoretically 
expected (58-61%) if the packing density is calculated as the ratio of the specific 
volume and the bulk volume, both determined with mercury at 350 kPa. If the 
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calculation is done with the envelope volume measured by SPOS, however, packing 
densities about 5% higher than predicted are obtained (72-74%). This can be 
explained by considering that the bulk volumes included in the calculation are 
determined with mercury under a pressure of 350 kPa. Due to the compression of 
the particle structure these values are smaller than they would be in an 
unpressurized state leading to an overestimation of the packing density. 
4.2 Intraparticulate volume 
According to their atomic or molecule diameters, the chosen intrusion media can 
penetrate to different degrees into the microspheres. They allow determining the 
intraparticulate volume, but rendering different results. There are several options to 
define the spatial dimensions of an atom or molecule. The kinetic diameter provides 
the most appropriate information for the estimation of the accessible pore size. This 
diameter - 0.36 nm for nitrogen and 0.26 nm for helium [20] - represents the 
diameter of the smallest pores into which the molecules or atoms can just penetrate. 
With these measuring gases the lower range of the microporosity can be 
determined. In case of mercury the intrusion capability depends on the applied 
pressure. Under the assumption of a cylindrical shape the minimum diameter dp of 
mercury-accessible pores, can be calculated from the pressure p using the 
Washburn equation: 
dp = -4 γ cos θ / p 
with a contact angle θ of 135° between mercury and PLGA and a surface tension γ 
of 485 mN/m [21]. At 350 kPa, the pressure applied during the low pressure 
measurement, pores with a minimum diameter of 3.9 µm are filled and sized and 
with a pressure of 200 MPa pores down to 6.9 nm are detected. This implies that 
the high pressure mode of mercury intrusion porosimetry is only suitable to 
determine pores in the meso- and macroporous range, whereas micropores can 
only be measured by gas pycnometry.  
As reference the helium and nitrogen pycnometric densities were determined for the 
pure PLGA in different morphological forms, which showed consistent values. Only 
the PLGA powder shows different values (ρ(He):1.2468 g/cm³ and ρ(N2): 
1.3831 g/cm³) which cannot be adequately explained.  
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Highest skeletal densities were found with pure PLGA granules and with the 
compressed polymer. The granules are transparent, which is an indication for a 
virtually pore-free, compact structure. A highly dense structure was also measured 
with particles prepared at 10°C. The He- and N2-pycnometric densities are only 
slightly lower than the values obtained with PLGA granules (He: Δρ = 1.41%, N2: 
Δρ = 1.27%) or compressed PLGA (He: Δρ = 1.81%, N2: Δρ = 1.28%). Despite the 
similar gaspycnometric densities, formulation 1 clearly differs from PLGA granules 
and tablets in its morphology and internal microstructure. This demonstrates that the 
skeletal density alone does not allow distinguishing between a compact body and a 
porous material. 
Different information on the intraparticulate volume is provided by the specific 
envelope volume, which is the reciprocal of the envelope density. Often it is 
assumed, that the specific envelope volume can be determined by low-pressure 
mercury intrusion porosimetry. Comparison of the specific volumes obtained by this 
method (0.7491 to 0.8591 cm³/g) (Tab. 2) with the envelope volumes calculated 
from SPOS (0.950 to 1.035 cm³/g) (Tab. 3) shows that, even under low pressure, 
mercury penetrates into the microspheres to a substantial degree. This is in 
accordance with Tonnellier [12] who found that mercury intrusion porosimetry is not 
an appropriate method to distinguish between intra- and interparticulate porosity. In 
order to measure the envelope volume of the spheres the intrusion medium must 
completely fill the interparticulate voids without infiltration of the porous particles. 
Because all the tested samples are particle fractions between 30 and 150 µm the 
smallest interspaces can be rated to about 5 µm (= 30/6 µm) according to the 
abovementioned consideration. According to the Washburn equation a pressure of 
about 350 kPa is necessary to guarantee that all these interparticulate pores (down 
to a theoretical diameter of 3.9 µm) are filled. As a consequence, however, mercury 
accesses also a certain fraction of intraparticulate pores which are in a similar size 
range (Fig. 2). Hence at least in case of samples with a broad size distribution, 
where the smallest interparticulate voids are similar in size to the largest 
intraparticulate pores, mercury intrusion is not a suitable method for determination of 
the particles’ envelope volume. Provided that the sample consists of spherical 
particles only, the optical method we have developed allows a precise determination 
of this parameter. 
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4.3 Porosity profiles 
The principle of the described method for studying the pore size distribution of 
microspheres is the combined application of three different intrusion media and an 
optical particle sizing method. The envelope volume is confined by a convex hull 
around the outer dimensions of each particle, whereas the specific volume 
determined with helium represents the volume of the mere polymer matrix. Thus the 
difference between both is the volume of voids within the material. Due to its smaller 
intrusion capacity a different pore volume is calculated when nitrogen is used 
instead of helium. Yet another value is obtained by mercury intrusion porosimetry. 
By combining these data porosity profiles can be obtained which provide information 
on the absolute pore volume and the pore size distribution. Figure 4 depicts the 
different types of the pore volume as percentages of the total particle volume, i.e. 
the envelope volume. The highest pore volume can be detected with helium, as its 
atoms have the smallest kinetic diameter of all applied intrusion media. An 
exception is formulation 1, which shows a pore volume filled by mercury of 21.2%, 
but a pore volume filled by helium of only 18%. This can also be interpreted as a 
result of a substantial collapse of the more fragile internal pore structure under the 
applied pressure during the mercury porosimetry measurement.  
 
Figure 4: Pore volumes filled by helium (□), nitrogen (■) and mercury (■) 
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The volume of these helium-accessible pores shows an increase from 18% for the 
sample prepared at 10 °C (formulation 1) to 24.8% for the microspheres prepared at 
35 °C (formulation 5). Neither the pycnometric data nor the mercury porosimetric 
measurements reflect this trend because it is almost exclusively caused by the 
change of the envelope volume. This emphasizes once more the importance of this 
parameter. In case of formulation 1 and 2 (preparation temperature 10 °C and 
20 °C, respectively) there is only little difference between the helium and nitrogen 
pycnometric data. This is an indication of a coarse pore structure with large pores, 
embedded in a tightly packed polymer matrix. These particles reveal an open 
macroporous structure which is highly accessible to all intrusion media (Fig. 2a) and 
microporosity is very low. Formulation 2 reveals a more graduated pore size 
distribution with a small fraction of microporosity but more than 85% of the total pore 
volume consists of voids larger than 3.9 µm.  
The presence of a small fraction of micropores in formulations 1 and 2 can be 
attributed to an incomplete solvent extraction at low temperatures (3% methylene 
chloride remaining after 6 h extraction). As drying took place at room temperature 
and thus above the glass transition temperature (21 °C), the PLGA matrix could 
densify since the polymer chains were still flexible resulting in a loss of 
microporosity. 
During extraction at higher temperatures a densified shell is formed around the 
particles as can be seen in Fig. 2b [22, 23]. At 30 °C the superficial solidification has 
to be regarded as a still relatively slow process which passes an extended 
transitional stage with a fragile polymer skin surrounding the solidifying droplets. 
Frequent disruptions of this skin resulting in a release of solvent portions and 
shrinkage of the particles could explain the porosity profile of formulation 3. The total 
porosity is similar to the one of formulation 1 and 2, but a substantial fraction of 
micropores is detected, whereas the macro- and mesoporosity is strongly reduced. 
With an increase in process temperature, the structure changes and the differences 
between helium and nitrogen measurements become more distinctive. Between 30 
and 35 °C the total porosity increases from 18 to 24.8% and a fraction of micropores 
occurs at 30 °C which is only accessible to helium but not to nitrogen. Expressed as 
a proportion of the total pore volume, this subfraction of micropores smaller than 
0.36 nm increases abruptly from 2-8% up to 22-34% as the preparation temperature 
reaches 30 °C. This suggests, that the structure becomes finely ramified, so that 
only small helium atoms can diffuse into the end sections of the pores, whereas they 
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are inaccessible to nitrogen. These “submicropores” are the main reason for the 
increase of total porosity at elevated extraction temperatures. At a process 
temperature above 30°C the polymer matrix is well hydrated and the concentration 
of residual solvent is very low at the end of the extraction process (< 0.7%). The 
glass transition temperature is therefore above room temperature (> 31 °C) and the 
polymer is dried in a rigid state. Under these conditions water acts as a porogen 
leaving sub-nanometer voids in the places from which water molecules are 
removed.  
In case of all formulations tested nitrogen and mercury fill almost the same fraction 
of pores. Although nitrogen is able to penetrate into pores which are about 10000 
times smaller than those accessible to mercury at 350 kPa the pore volume 
measured with nitrogen is not more than 1.4% higher than the volume determined 
with mercury. Helium, however, which atoms are only a little smaller than N2 
molecules with respect to their kinetic diameters, is able to reach an additional pore 
volume of up to 6.4% compared to nitrogen. This indicates the presence of two 
separate pore populations, one smaller than 0.36 nm and another larger than 
3.8 µm, with not more than 6% of the total porosity lying inbetween. This is the 
reason for a rather low BET surface area of only 0.41 m²/g. From the particle size 
distribution the envelope surface area of the microspheres was calculated as 
0.07 m²/g which amounts already to 17% of the total specific surface area. Although 
the microspheres exhibit pores to a substantial degree (Fig. 2) their internal surface 
area is only about 0.34 m²/g. This can be explained by the fact, that on the one hand 
macropores larger than 50 µm contribute only little to the surface area and on the 
other hand the majority of the micropores is smaller than the kinetic diameter of 
nitrogen and is therefore not accessible to the measuring gas used for the BET 
measurements. 
The appearance of two separate intraparticulate pore populations suggests their 
formation by different mechanisms. The larger voids are obviously created by 
shrinkage and rupture of the drying polymer or are a result of larger channels and 
pockets in the material, which were initially filled with sequestered water [24, 25]. 
The micropores, by contrast, are the remaining vacancies which are formed when 
water molecules evaporate from the hydrated polymer [26]. 
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5 Conclusions 
As the porosity represents a central feature of microspheres for pharmaceutical use 
as well as for other applications it is a key to understanding the mechanisms of 
formation and behavior of such complex structured materials. So far the porosity is 
often estimated by SEM micrographs, but this method provides only information 
about the macroporous structures inside the microspheres. Mercury intrusion 
porosimetry is an established method to determine the specific pore volume and the 
pore size distribution of solid materials but (i) does not provide any information on 
the porosity as defined by ASTM, (ii) is not able to distinguish between inter- and 
intraparticulate porosity, and (iii) is often biased by compression induced structural 
changes of the specimen. Because of these limitations further techniques are 
needed to supplement these methods. Our novel combined method is able to 
determine the porosity according to the ASTM definition (pore volume per total 
volume) and provides “fingerprints” of the pore size distribution covering a larger 
size range than any single method. At least three different pore size fractions can be 
distinguished including micropores smaller than 0.36 nm, in which only helium can 
diffuse, pores ranging from 0.36 nm to 3.9 µm in which nitrogen, but not mercury 
can penetrate, and macropores larger than 3.9 µm which are accessible to all 
intrusion media. With this comprehensive information it is possible to uncover 
structural properties even in the submicroscopic scale thus gaining deeper insight 
into the application-specific functionalities of microparticles. 
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 CHAPTER 7 
Summary of the Thesis 
The objective of this work was to investigate the role and the interactions of the 
process parameters in a solvent extraction / evaporation process for the preparation 
of PLGA microspheres containing a poor water soluble drug substance.  
For the preparation of the emulsion which is fed into the extraction medium, the 
solubility of both the drug substance and PLGA play a crucial role for the 
solidification rate and the crystalline or amorphous state of the drug in the resulting 
particles. Methylene chloride is one of the most common solvents utilized for in the 
solvent extraction / evaporation process. On basis of the determined partial solubility 
parameters of the drug substance and those of PLGA, benzyl alcohol and butanol 
were chosen as co-solvents for the preparation process. Benzyl alcohol reduced the 
encapsulation efficiency of the drug substance and rendered crystalline drug 
substance in the microparticles because its solubility parameters are similar to the 
ones of the drug substance. This is reflected in a better solubility of the drug 
substance and its extraction along with the solvent from the particles. In 
microspheres prepared with butanol the drug substance was present in a completely 
amorphous state. Despite of the different drug substance morphology, the particles 
showed an almost identical drug release profile, suggesting that the amorphous 
drug substance re-crystallizes when aqueous medium diffuses into the particles 
upon dissolution or in vivo.  
The size of the emulsion droplets, respectively of the resulting particles, has also a 
strong influence on their degradation and drug release rate. The droplet size is 
mainly determined by the primary emulsion and the parameters used for its 
preparation. Applying a static mixer these are the pump rates of the organic and the 
aqueous phase and the number of mixing elements, which spilt up and recombine 
the emulsion stream. An efficient way to investigate this process is to plan the study 
by applying Design of Experiments (DoE). Having a defined composition of the 
organic and aqueous phase the droplet size is influenced only by the pump rates of 
both phases and the numbers of mixing elements. The higher the velocities of both 
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phases are the finer become the resulting emulsion droplets. The number of mixing 
elements influences strongly the width of the droplet size distribution. 
During processing the droplets and forming particles can undergo size and 
morphological changes. The Focused beam reflectance measurement is a versatile 
tool to monitor especially the transformation of liquid emulsion droplets to solid 
particles and occurring surface changes. Furthermore events like the leakage of 
drug substance into the external medium and its precipitation therein can be 
detected by this online-measuring technique.  
The extraction of the organic solvent and thus the solidification of the emulsion 
droplets to hardened microparticles are strongly influenced by varying the process 
temperature of the external phase. As long as the polymer chains stay flexible due 
to (i) a sufficient amount of organic solvent in the polymer matrix or (ii) a sufficiently 
high process temperature, above the glass transition temperature of the polymer 
matrix, the morphology of the particles can change during processing. The rate of 
solidification in turn has major impact on the final particle size, the encapsulation 
efficiency and the drug release. A slow removal of the organic solvent from the 
hardening particles leads to irregularly shaped or broken microspheres and to a 
leakage of the drug substance into the extraction medium. A certain solidification 
rate is necessary to encapsulate the drug substance efficiently and to obtain 
spherical shaped microparticles. A dense microparticle structure is obtained by 
applying a process temperature, which is above the glass transition temperature of 
the hydrated and solvated particles. Another process modification is the 
resuspension of the resulting microspheres in an ethanol-water-mixture, which 
resulted in a very dense outer shell around a fine porous interior structure.  
As the porosity of the polymer matrix strongly determines the degradation rate and 
the degradation mechanism, it has a major impact on the drug release rate from 
microparticles. So far it is often estimated by SEM micrographs, a method which 
provides only information about the macroporous structures inside the 
microspheres. The mercury intrusion porosimetry is an established method to 
determine the specific pore volume and the pore size distribution of solid materials 
but it is not able to distinguish between inter- and intraparticulate porosity, and in 
case of microspheres structural changes due to compression during the 
measurement can bias the results of this analytical method. With a novel method, 
combining the calculation of the envelope volume obtained by a particle sizing 
measurement based on light obscuration and the skeletal volumes determined by 
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nitrogen and helium pycnometry and mercury intrusion porosimetry three different 
pore size fractions could be distinguished. With these porosity “fingerprints” 
structural properties even in the submicroscopic scale can be detected. This helps 
to gain deeper insight into the underlying formation mechanisms and the 
application-specific functionalities of microparticles. 
This work describes the structure formation in a solvent removal process and 
demonstrated different possibilities to modify the particle morphology and functional 
characteristics at the various process steps. The correlation of different 
morphologies and the decisive properties of the microspheres, amongst others 
release of the drug substance, were shown. With special analytical methods a 
deeper insight into the encapsulation process of a poor water soluble drug 
substance in a PLGA matrix and the transformation from liquid e emulsion droplets 
to solid particles was obtained. 
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Annexes 
Abbreviations 
API Active pharmaceutical ingredient 
ASTM American Society for Testing and Materials 
BET Brunauer Emmett Teller 
BSI British Standards Institution 
CCF Central composite face-centered 
CLD Chord length distribution 
CO2 Carbon dioxide 
DAD Diode array detector 
DoE Design of Experiments 
DSC Differential scanning calorimetry 
e.g. for example 
GAS Gas antisolvent process 
FBRM Focused Beam Reflectance Measurement 
FDA Food and Drug Administration (US) 
Fig. Figure 
h hour 
i.e. that is 
IUPAC International union of pure and applied 
chemistry 
Mw Molecular weight 
PAT Process Analytical Technology 
PGSS Particles from Gas Saturated Solutions 
process 
PLA polylactide acid 
PLG polyglycolid acid 
PLGA poly(lactide-co-glycolid) acid 
PVA polyvinyl alcohol 
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PVC polyvinylchloride 
PSD particle size distribution 
RED Relative Energy Difference 
r.h. relative humidity 
resp. respectively 
RT room temperature 
SAS Supercritical antisolvent process 
SCF supercritical fluid 
SEDS Solution Enhanced Dispersion by Supercritical 
Fluids 
SEM Scanning electron microscopy 
SPOS Single Particle Optical Sensing 
Sqr. wt Square weighted 
Tab. Table 
Tg Glass transition temperature 
Tris tris(hydroxymethyl)aminomethane 
XRPD X-ray powder diffraction 
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